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GENERAL INTRODUCTION 
Vitamin K is a general term that refers to a series of compounds with the general 
structure of polyisoprenoid-substituted naphthoquinone. Vitamin K is traditionally classified 
into KI (phylloquinone) and K2 (menaquiones), according to its origin from plants or 
bacteria, respectively. A group of synthetic menadione derivatives, such as menadione 
sodium bisulfite, also have biological activity of vitamin K. The K vitamins are essential 
cofactors for microsomal vitamin K-dependent carboxylases, which catalyze a post-
translational conversion of glutamyl residues in the nascent precursors to y-carboxyglutamyl 
residues (Gla) in their respective mature proteins. Vitamin K is required for the maintenance 
of normal levels of blood clotting factors such as Factors II. VII. IX and X. Recent research 
progress indicates that vitamin K is also involved in a large variety of physiological 
functions. The influence of vitamin K status on bones has received substantial attention in 
recent years. Vitamin K status of postmenopausal women is related to the incidence of 
osteoporosis and to some related plasma parameters, such as osteocalcin. Dietary 
supplemental vitamin K reduces the loss of cancellous bone in laying hens during 
reproduction. However, information in the literature on the effect of vitamin FC on bone or 
related parameters in young growing animals is scarce and inconclusive. There continues to 
be a high incidence of leg problems in fast growing young turkeys. Young turkeys, therefore, 
should serve as a good model for studies to determine the influence of dietary vitamin K on 
bone development and related parameters. 
Recent evidence indicates an interaction between the biological functions of vitamin 
D and vitamin K. Leeuwen et al. (1996) reported that expression of osteocalcin genes was 
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regulated by vitamin D. Takede et al. (1994) postulated that the vitamin D receptor, which is 
a nuclear transcription factor, binds to the vitamin D response elements of the osteocalcin 
genes and regulates their expressions. Sergee and Norman (1992) reported that l,25-(OH)2 
D3 receptor (VDR) underwent y-carboxylation in the presence of K1 in vitro, and 15 to 25% 
of Glu residues in the VDR were carboxylated in vivo. 
The objectives of the research reported here are 1) to determine the KI requirement of 
turkey poults, and 2) to determine the influence of dietary tCI on bone mineralization and 
related plasma parameters in young turkeys fed diets that were adequate or deficient in D3. 
Dissertation Organization 
The dissertation is divided into a Literature Review followed by two manuscripts and 
a General Conclusion. 
The first manuscript will be submitted to publish in Poultry Science with the 
authorship of Shihou Jin and Jerr>' L. Sell. The second manuscript will also be submitted for 
publishing in Poultry Science under the authorship of Shihou Jin, Jerry L. Sell and John W. 
Suttie. Shihou Jin is the senior author for both of these two manuscript. 
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LITERATURE REVIEW 
Chemistry and Sources of K Vitamins 
Chemistry and Nomenclature 
K. vitamins (from tlie Danish, FCoaguIation) are polyisoprenoid-substituted 
naphthoquinones. The parent structure of the vitamin BC series is 2-methyl-I, 4-
naphthoquinone (commonly known as menadione). This compound, as far as is known, does 
not occur in nature but does possess biological activities in vertebrates after it has been 
alkylated to one of the menaquinones by animal tissues in a process whereby a 
geranylgeranyl side chain is added at the three position of the parent ring. All naturally 
occurring K vitamins possess the same naphthoquinone ring structure as menadione but 
differ in the structures of the side chains at the three-position. They are traditionally 
classified into two groups according to their origin from either plants or bacteria. The 
primary form of vitamin K. in plants is phylloquinone (vitamin Kl). Bacteria, on other hand, 
synthesize a family of compounds called menaquinones (vitamin K2) with side chains based 
on different number of repeating isoprenoid units. These compounds are generally referred to 
as MK-rt. where n is the number of isoprenoid units of which the side chain is composed. 
Natural menaquinones ranging from MK-4 to MK-13 are produced by bacteria. The double 
bonds in the side chain of menaquinones may be in either trans or cis configuration. Some 
bacteria also synthesize menaquinones with partially saturated side chains. The additional 
hydrogen atoms in these menaquinones are indicated by the prefix such as dihydro-, 
tetrahydro- and so forth. 
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Sources of K Vitamins 
Until recently, there has been little accurate and comprehensive data on the levels of 
fC vitamins in feed and foods. In part, as Shearer et al (1996) indicated, this has been due to 
the lack of any perceived threat to health or well-being from a dietary deficiency of vitamin 
K as manifested by its classical fiinction in blood coagulation, and partly due to the lack of 
suitable analytical techniques for measuring vitamin K in feed or food- As a consequence, the 
feed composition tables in the most recent NRC (1994) publication for poultry and NRC 
(1998) for swine do not include data for vitamin K. 
Evidence obtained in recent years indicates that a subclinical deficiency of vitamin K, 
while having no impact on homeostasis, may have an effect on bone in aged humans. These 
observations have altered the perception of the functions and health effects of vitamin K, and 
provide a new impetus to obtain reliable data for the vitamin K contents in himian foods. 
However, there is still little new information about vitamin K in animal feed. Therefore, most 
information cited in the following review is from data in foods that were analyzed by high 
performance liquid chromatography in recent years. 
Phylloquinone (Vitamin K1) 
Vitamin Kl is assumed to be widely distributed in nature. Booth et al. (1993, 1995) 
reported that the dark green, leafy vegetables such as collards, and spinach as well as other 
green vegetables such as broccoli contain the greatest amounts of phylloquinone (110—960 
fj.g/100g). Ferland and Sadowski (1992) reported that vitamin Kl concentrations in green 
leafy vegetables are greatly affected by level of maturity and geographic locations where 
they are growoi. In general, vitamin Kl content increases during maturation, and on a wet 
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weight basis vitamin Kl is more concentrated in mature green vegetables than in young ones. 
Vitamin Kl concentrations in green vegetables are influenced by both the soil and 
climatological conditions (Ferland and Sadowski, 1992). Ferland and Sadowski (1992) also 
reported that the distribution of vitamin Kl is not uniform even in the same plant; the outer 
leaves of cabbage contain 3 to 6 times more vitamin Kl than that of the inner leaves. 
Other good sources of vitamin Kl include some species of algae, such as purple laver 
and hijiki. which contain about 1385 and 327 ug vitamin Kl/lOOg, respectively. Some oil 
seeds are also good vitamin Kl sources. Booth et al. (1993) reported that dry soybean seeds 
contain substantial amount of vitamin Kl. however, the contents of vitamin Kl in other oil 
seeds are very low. Raw peanut and sesame seeds contain only 0.2 and 8 fig of vitamin 
Kl/lOOg. respectively. Vegetable oils that are derived from vegetables or seeds contain large 
amount of vitamin Kl. are also good sources of vitamin Kl. The vitamin Kl concentrations 
of some commonly used vegetable oils are listed in Table 1. 
Booth et al. (1996) reported that hydrogenation of vitamin Kl-rich vegetable oils, 
such as soybean, canola. and cottonseed oil, converts vitamin Kl to dihydro-vitamin Kl, 
with an overall loss of the vitamin that is proportional to the degree of hydrogenation. 
Therefore, any foods or diets that are otherwise poor sources of vitamin Kl might contain 
appreciable amounts of dihydro-vitamin Kl if they contain certain kinds of hydrogenated oils 
or are processed with these kinds of oils 
Cereal grains and their milled products appear to be low in vitamin Kl. Shearer et al 
(1996) reported that vitamin Kl contents in maize and wheat are 0.3 and 8 fXg/lOOg, 
respectively; cmd 7 and 10 (ig/lOOg for barley and oats. Booth et al. (1993) reported that 
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TABLE I. Phylloquinone concentrations in some commonly used vegetable oils 
Oil Booth et al. (1993) Shearer et al. (1996) 
^ig/lOOg 
Com oil J J 
Palm oil — g 
Sunflower oil 9 6 
Peanut oil 0.7 — 
Sesame oil 10 — 
Olive oil 49 80 
Soybean oil 193 173 
vitamin K1 content in com flakes is 0.04 ^g/lOOg whereas the analogous values for wheat 
flour and barley flour are a little bit higher with values of 7 and 1 jag/lOOg, respectively. 
Menaquinones 
Compared with phylloquinone, information about foods or feeds as a source of 
bacterially synthesized menaquinones is scarce. The livers of various animal species were 
long though to be a good source of a wide variety of long-chain menaquninoes with side 
chains ranging from MK-6 to MK-13 (Duello and Matschiner, 1971; Mitschiner and 
Amelotti. 1968). However, recent quantitative analysis by high performance liquid 
chromatography revealed that only livers of ruminant species contain high enough 
concentrations of some menaquininones likely to be of nutritional significance (Hirauchi et 
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al., 1989). Cheese (Shearer et ai, \996) and yogurt (Vemeer et ai, 1995) also have been 
reported to contain great concentrations of menaquinones. 
The intestinal microbial flora produce menaquinones that might be absorbed by host 
animals. Ramotar et al. (1984) concluded that Escherichia coli and Bacteroids species and 
some gram-positive, anaerobic, non-spore-forming bacilli commonly colonizing in the 
intestines all produce menaquinones. Quantitative culture of human intestinal content showed 
that the most prevalent orangisms from the terminal ileum down to distal colon are 
Escherichia coli and Bacteriods species (Conly and Stein. 1992). Therefore, Escherichia coli 
and Bacteriods species are among the most dominant microbial flora in the intestines that 
produce menaquinones. The menaquinone concentrations in the different segments of human 
intestines are listed in Table 2. 
Synthetic menadione derivatives 
There are three major menadione derivatives that are commonly used in diet 
fortification. These are menadione sodium bisulfite, menadione dimethylpyrimidinol 
bisulfate. and a recently available compound, menadione nicotinamide bisufite. All these 
compounds have to be alkylated first in animal tissues to be fionctional as K vitamins in vivo. 
Menadione nicotinamide bisufite in addition to being a source of vitamin K, is also a 
bioactive source of niacin. 
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TABLE 2. Menaquinone concentrations in the contents of different segments of 
human intestines (Conly and Stein, 1992) 
Site MK4toMk-9 Mk-9,MK-10 Total MK 
Hg/g dry weight 
Distal Colon 5.55 14.54 19.85 
Colon 1.64 4.50 6.10 
Ileum 0.69 1.16 1.85 
Terminal ileum 0.92 7.93 8.85 
Jejunum 0.01 0.02 0.03 
Absorption of K Vitamins 
The absorption site of K vitamins is believed to be in the proximal part of the 
intestines (Shearer et al. 1974; Hollander and Rim, 1976). Howrever, absorption of 
menaquinones has been reported to occur in the distal intestines including the jejunum 
(Ichinashi et al. 1992; Hollander et al., 1977), ileum (Hollander and Rim, 1974; Hollander et 
al.. 1977) and the colon (Ichinashi ef a/. 1992; Hollander er a/., 1977). Compared with 
absorption in the colon, the absorption of MK-4 in the jejunum was much more efficient 
(Ichinashi et al. 1992). Groenen-van Dooren et al. (1995), after comparison of bioavailability 
of phylloquinone and menaquinones administered orally or colorectally, respectively, 
concluded that the colonic absorption of K vitamins is extremely poor. 
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The absorption mechanism of K vitamins is similar to other lipid substances. It 
requires the presence of bile salts and products of pancreatic lipolysis to form micelles. 
Shearer et al. (1974) reported that biliary obstruction or the inclusion of nonabsorbable anion 
exchange resin cholestyramine that binds to bile salts impaired the absorption of 
phylloquinone. This impairment was also observed under conditions of pancreatic 
insufficiency or inadequate ingestion of lipid that leads to a reduced generation of solutes of 
mixed micelles (Shearer er a/.. 1974; Vermeeref a/., 1995). Hollander er a/. (1997) reported 
that the absorption rate of menaquinone (MK-9) in situ in the ileum increased as bile salt 
concentrations increased in the perfusate. However, these authors observed that unsaturated 
long chain fatty acids, such as oleic or linoleic acid adversely affected the absorption of 
menaquinones. When these types of fatty acids were added in the perfusate the absorption of 
menaquinone was significantly decreased. 
The absorption rate of phylloquinone administered in free-form is very rapid. 
Vermeer el al. (1995) reported that 1 hour after oral administration of phylloquinone a very 
high level of vitamin K1 was detected in plasma, and about 4-5 hours after administration 
plasma concentrations reached a plateau. The absorbability of fi-ee-form phylloquinone is 
believed to be very high, about 80%. under normal conditions (Shearer et al.^ 1974). 
However, phylloquinone occurs naturally as a component of the photosynthetic electron 
transport system in pleints; it exists exclusively in the thylakiod membranes of the chloroplast 
in combination with other substances (Lichtenthaler, 1993). The binding is very tight and 
leads to ver>' poor and slow absorption of phylloquinone from vegetable sources. Vermeer et 
al. (1995) reported that even with simultaneous ingestion of fat, no significant concentration 
of phylloquinone could be detected in plasma until 5 hours after ingestion of spinach. The 
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absorbability of phylloquinone from vegetables is very low averaging less than 10% 
(Vermeere/a/.. 1995) 
The newly recognized dihydro-vitamin Kl that is produced primarily during the 
hydrogenation of vitamin Kl-rich vegetable oils, has also been shown to be absorbable. 
Booth et al. (1996) reported that, after dietary intake of a hydrogenated vitamin Kl-rich 
vegetable oil. dihro-vitamin KI is detectable in human plasma. 
Most of the naturally occurring menaquinones have been confirmed to be absorbable 
by in vitro (Hollander and Rim. 1976), in situ (Ichihashi et al. 1992) and in vivo (Hollander et 
al.. 1977) procedures. The absorption rates of menaquinones are affected by their side chains. 
Compared to phylloquinone. menaquinones with short side chains such as MK-4 might be 
absorbed more quickly, as indicated by the more rapid increase in plasma concentration 
following oral administration, compared to that of phylloquinone (Sakamoto et al. 1994). 
This finding is consistent with the observation that plasma vitamin Kl level decreased more 
slowly compared to that of MK-4 following the peak after oral administration (Sakamoto et 
al. 1996). However, menaquinones with long side chains such as MK-9 might be absorbed 
more slowly compared to phylloquinone. Will and Suttie (1992) reported that MK-9 
concentration in rat plasma was lower during the first few hours after ingestion of a diet 
containing MK-9 compared to phylloquinone concentrations in rats that ingested 
phylloquinone. Plasma phylloquinone increased dramatically following ingestion and then 
decreased sharply a few hours later. Akiyama et al. (1995) compared the intestinal absorptioa 
of menaquinones containing varying number of isoprene units (from I to 14) and observed 
that 6 hours after oral administration, the concentrations of corresponding MKs in plasma 
were increased in rats that received MK-0, and MK-4 to 11, but there were no or very little 
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change of the concentrations of corresponding MKs in plasma in rats that received MK-1,2, 
3 and MKs with more than 12 isoprene units. They concluded that the number of isoprene 
units of MKs is an important factor in its absorption. 
Menaquinones can be synthesized by the microbial flora in the lower intestinal tract, 
and there is little doubt that some of these menaquinones are absorbed. However, the 
question of whether intestinally synthesized menaquinones can be absorbed in nutritionally 
significant amounts by the host is long-debated for some species, including the human being 
and rat. As mentioned earlier. K vitamins are absorbed mainly in the proximate small 
intestines and v'er\' little is absorbed in the colon, as reported by Groenen-van Dooren et al. 
(1995) and Ichihashi et al. (1992), whereas the segment of the human intestines that contains 
the high concentrations of menaquinones is the colon. These observations lead to doubts of 
the importance of intestinally microbially synthesized menaquinones for the host. However, 
there have been observations that antibiotic therapy sometime caused hypoprothrobinaemia 
in humans (Freeh et al.. 1967: Pineo et al. 1973). Furthermore, germ-free rats have a higher 
requirement for vitamin K than normal rats (Gustafsson et al., 1962). These observations 
indicate some role for menaquinones produced by intestinal microbial flora for the host. 
Recent analysis showed that the content of terminal ileum also contains a substantial amount 
of menaquinones (total menaquinones 8.85 |j.g/ g DM)(Conly and Stein, 1992), and the ileum 
has been shown to absorb menaquinones very well (Hollander et al., 1977). On the basis of 
this information. Shearer concluded (1996) "the most promising site of absorption would 
seem to be the terminal ileum, which contains reasonable concentration of menaquinones and 
of bile salts." Conly (1992). after reviewing available literature regarding production and 
liberation of menaquinones from bacteria, stated that the preponderance of the evidence 
suggests that bacterially synthesized menaquinones, particularly in the ileum, can and do 
contribute tovvju-d vitamin fC requirements in humans in maintaining coagulation 
homeostasis, especially during periods of episodic dietary lack of the vitamin. 
Transport, Storage of K Vitamins 
Transport of K Vitamins in Plasma 
After enteral absorption, phylloquinone is incorporated into chylomicrons and 
transported into the circulatory system by the lymphatic system in mammals or by the hepatic 
portal circulation in birds. The transportation of menaquinones from the intestines to the 
circulatory system most likely is similar to that of phylloquinone, although there might be 
some minor differences. Ichihashi et al. (1992) reported that even in mammals such as rats 
menaquinones could be absorbed directly into hepatic portal circulation. This was especially 
true for the menaquinones absorbed from the colon. 
Once in the circulator}' system, K vitamins mainly, phylloquinone, MK-7, and 
possible MK-8 and MK-9. are predominately associated with the triglyceride-rich 
lipoproteins (Kohlmeier el ciL. 1996). These lipoproteins are from two families: very low 
density lipoproteins and their derivatives, which are formed in the liver, and chylomicrons 
and their derivatives which are formed in the intestines. There are much smaller fractions of 
K vitamins carried by low density or high density lipoproteins. The proportion of 
phylloquinone and MK-4 carried by the triglyceride-rich lipoproteins was more than 50% of 
the total amount in the plasma (Kohlmeier et al, 1996). The observation of a strong positive 
correlation between phylloquinone and plasma glyceride (Sadowki et ai., 1989; Saupe et al., 
1993) is consistent with the conclusion that phylloquinone is primarily transported by 
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triglyceride-rich lipoproteins. Further delineation of this association comes from the 
demonstration that fasting plasma phylloquinone concentration is strongly influenced by the 
common genetic polymorphism of apolipoprotein E (apoE), being greatest in individuals 
with the apoE2 variant, intermediate in apoE3, and lowest in apoE4 (Shearer, 1995). This fits 
well with the conclusion that the rate at which chylomicron renmants are cleared from 
circulation in individuals, differs according to the variant of apoE: fastest for individual with 
apoE4. intermediate for apoE3 and slowest for people with variant of apoE2 (fCohlmeier et 
al.. 1996: Shearer. 1995). 
Chylomicrons and their remnants, and the associated vitamin K, are thought to be 
primarily taken up by the liver. However, Hussain et al. (1989) reported that bone marrow 
also plays an important role in the removal of chylomicrons and their remnants. Kohlmeier et 
al. (1996) concluded on the basis of animal experiments that nearly all intestinal lipoproteins 
are removed from the circulation by the liver, spleen and bone marrow within less than 1 
hour. Accumulation of the intestinal lipoproteins by these three tissues is because the 
receptor-bearing cells in these tissues have direct access to circulation and acquire 
lipoproteins preferentially. Among the bone marrow cells that have direct access to the 
intestinal lipoproteins are stromal and mesenchymal cells (Kohlmeier et al.. 1996). These 
cells are the obligator}' precursors of all bone forming cells (Baron, 1993). KoUmeier et al. 
(1996) postulated that the migration of these stromal and mesenchymal stem cells to the sites 
of bone resorption responding to appropriate stimuli and carrying the amounts of vitamin K 
they extract while residing in bone marrow, is the final step of vitamin K transportation from 
the circulatory system to bone tissue. 
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Clearance of K Vitamins from Plasma 
Being firmly associated with the lipoproteins of intestinal origin and other 
triglyceride-rich lipoproteins. K vitamins share the same metabolic fate as that of these 
lipoproteins. Many acquired and constitutional factors are known to affect clearance of 
chylomicrons and their remnants and other triglyceride-rich lipoproteins from the circulatory 
system. One such example is the different variants of apolipoprotein E. 
Under normal conditions, radioactive labeled phylloquinone was cleared from the 
circulation very rapidly following either oral or intravenous administration (Shearer et al., 
1972). Two and eight hours after administration only about 10 and 1% of the initial 
radioactivity remained in the plasma, respectively. Shearer et al. (1974) made an estimate of 
the clearance kinetics of phylloquinone. and concluded that the half-time for the first and 
second exponential phases of phylloquinone clearance in plasma was 20-24 and 120-150 
minutes, respectively. This result was consistent with the report of Bjorason et al. (1980) 
who showed that the half-ti.me values of first and second exponential phases of 
phylloquinone in plasma were 26 and 199 minutes, respectively. 
Compared with phylloquinone, Sakamoto et al. (1996) reported that after intravenous 
administration. MK-4 was cleared quicker. One hour after administration, plasma MK-4 level 
was about 3% of the original concentration, whereas the value for K.1 was 74%. They 
postulated that vitamin K1 may be more hydrophobic and might have a greater affinity than 
MK-4 for lipoproteins in plasma. 
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Storage, Distribution and Mobilization of K Vitamins 
Phylloquinone in plasma might be taken up by different tissues. Of these tissues, the 
liver plays a major role. Bell and Matschiner (1969) reported that, after parenteral 
administration of vitamin K.1. as much as 50% of the administered dose appears in the liver 
within 1 hour. After oral administration, the liver contains about 20% of the administered 
dose within 2 hour. This is consistent with the observation by Wiss and Floor (1966) and 
Kindberg and Suttie (1989) who reported that after an oral ingestion the concentration of 
vitamin K1 in the liver increased dramatically and reached a peak within a few hours. The 
vitamin K1 taken up by the liver after the administration is released from the liver to other 
tissues. Wiss and Gloor (1996) and Kindberg and Suttie (1989; 1992) reported that the 
vitamin K1 level in the liver decreased to a very low level within 20—24 hours following the 
peak after administration. Wiss and Gloor (1996) observed that the level of vitamin K1 in 
e.vtrahepatic tissues concomitantly increased with the decline of vitamin K1 in the liver. 
These observations indicate that the liver serves as a temporary storage for part of absorbed 
vitamin KI. Of the total vitamin K1 store in the body. 10% is stored in the liver in humans 
(Shearer et al.. 1988). and this store is very labile. Under conditions of severe dietary 
depletion, the liver store is reduced to about 25% of the original concentration (Usui et al. 
1990). Within hepatocytes. vitamin Kl is mainly located in microsomes. Bell and Matschiner 
(1969) reported that the relative distribution of radioactivity after administration of ^ H-
phylloquinone in hepatocytes was: nuclei, 13%; mitochondria, 9%; microsome, 63%; and 
cytosol. 14%. 
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Although the liver is a major site for vitamin K1 storage, phylloquinone is widely 
distributed in the body and can be detected in most tissues, such as muscle, spleen, kidney 
(Hirauchi et al. 1989) and bone (Hodges et ai, 1993). Concentrations of phylloquinone in 
different tissues of some farm animals are listed in Table 3. 
TABLE 3. Phylloquinone concentrations of different tissues in some 
farm animals (Hirausiii et al., 1989) 
Species Liver Spleen Kidney Heart Muscle 
ng/g 
Chicken 25.2 7.7 J.J 5.5 2.3 
Pig 0.5 0.5 0.2 0.3 1.4 
Horse 76.7 23.7 5.8 14.5 14.9 
Bovine 18.4 2.8 1.9 2.4 3.1 
There is evidence to suggest that mobilization of menaquinones in animal tissues is 
different from that of phylloquinone. Sakamoto et al. (1996) reported that, compared with 
phylloquinone. intravenous administered MK-4 was taken up by the liver more rapidly, 
which leads to a more rapid accumulation of MK-4 in liver. MK-4 stores in liver also might 
be more easily mobilized compared with these of phylloquinone. Sakamoto et al. (1996) 
observed that concentrations of MK-4 in liver decreased to 8.5% of peak values within 5 
hours after an intravenous administration, whereas values for K1 were 53% 6 hours after its 
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peak. Will and Suttie (1992) compared the metabolism of phylloquinone and menaquinone 
with a long side chain (MK-9). Their results showed that the initial rate of hepatic turnover of 
phylloquinone was two to three times as rapid as that of MK-9. 
The storage and distribution of menaquinones are also different from that of phylloquinone. 
Shearer et ciL (1996) stated that the liver store of menaquinones, some with long side chains, 
constitutes 90% of the total body pool in the human. This amount is much larger than that of 
phylloquinone, which is only about 10% (Shearer et aL. 1988). However, this might not be 
true for all MKs. especially for some of MKs with short side chains such as MK-4. Miura et 
al. (1990) and Tliijssen and Dritlij-Reijinder (1994) reported that some extrahepatic tissues, 
such as brain, pancreas, and bone etc. contain very high level of MK-4. Hirauch et al. (1989) 
reported that MK-4 concentrations in spleen, heart and muscle of chicken were 17, 26, 39 
times, respectively, of the concentrations of vitamin Kl in these tissues. Menaquinone 
concentrations of different tissues in some farm animals are listed in Table 4. 
Metabolism of K Vitamins 
Conversion of Phylloquinone to Menaquinone-4 
The major form of K vitamins from plant sources is phylloquinone. Studies of 
vitamin K metabolism demonstrated that orally ingested phylloquinone could be converted to 
menaquinone-4 (Billeter and Martius, 1960: Billeter et al.. 1964). More recently. Will et al. 
(1992) reported that chickens fed diets containing phylloquinone as the only source of 
vitamin K have a very high level of MK-4 in plasma and liver. Suzuki et al. (1997) reported 
that as phylloquinone level increased, the concentrations of MK-4 in yolks increased in 
parallel. This conversion of phylloquinone to MK-4 also occurs in rats. Will et al. (1992) 
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TABLE 4. Concentrations of menaquinones in different tissues of 
farm animals (Hrauchi et al. 1989) 
Species liver Spleen muscle 
MK-4 MK-7 MK-9 MK-4 MK-7 MK-9 MK-4 MK-7 MK-9 
ng/g 
Bovine 8.2 181.8 15.3 7.9 1.4 0.6 34.3 0.3 
Horse 2.1 2.3 1.2 0.7 0.9 0.4 2.0 2.3 
Pig 5.9 6.1 5.6 6.3 3.9 2.4 9.4 0.3 
Chicken 39.6 ND' 0.4 133.1 ND ND 89.9 ND 
' ND stands for not detectable 
reported that rats fed diets containing phylloquinone as the sole source of vitamin K 
contained detectable MK-4 in the liver and plasma but in much lower concentrations than 
those observed in chickens. Tliijssen and Drittij-Reijnders (1994) reported that 
supplementation of KI in diets resulted in increased MK-4 levels in the pancreas, salivary 
glands and sternum of rats. 
The mechanism of conversion of phylloquinone to MK-4 has been proposed to be 
dealkylation of orally ingested phylloquinone by bacteria in the gut, and then alkylation in 
animal tissues (Will et al. 1992). However, the observation that intravenous administration of 
phylloquinone also increased the levels of MK-4 in the liver and plasma of chickens (Will et 
al.. 1992). and the pancreas and sternum of rats (Thijssen and Drittij-Reijners, 1994), 
suggests the possibility of an alternate pathway that has not yet been determined, for 
conversion of phylloquinone to MK-4 in animal tissues. 
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Conversion of Menadione to Menaquinone-4 
The commonly supplemented vitamin K sources in diets are menadione derivatives 
such as menadione sodium bisulfite. These derivatives have to be alkylated in animal tissues 
before they are functional. Dialameh et al. (1970) reported that menadione could be 
enzymaticcilly alkylated to menaquinones by chicken liver in vitro and by animal tissues in 
vivo. When radioactively labeled menadione was administered to chickens and rats, labeled 
MK-4 was isolated from the livers of the two species. However, the conversion from 
menadione to MK-4 is not an efficient process. Dialamen et al. (1971) reported that the 
extent of conversion, at best, by liver is 0.01-1% of the administered dose of menadione, with 
the highest conversion occurring in the chick. 
Vitamin K-vitamin K-2,3 Epoxide Cycle 
Fiesh and his colleagues (1941) first synthesized the 2,3-epoxide of phylloquinone 
and showed that it was rapidly converted to vitamin K in animal tissues. Approximately 30 
years later. Matschiner el al. (1970) reported that phylloquinone-2,3-epoxide is an 
intermediary metabolite in phylloqinone metabolism in rats. These observations provide the 
brief outline of the vitamin K-vitamin K-2,3-epoxide cycle. Many details of the cycle are 
provided through ±e study of enzymes involved in the cycle, notably vitamin K epoxidase, 
vitamin K-2.3-epoxide reductase and vitamin K reductase. 
Willingham and Matschiner (1974) first reported that isolated liver microsomes had 
phylloquinone "epoxidase" activity. A subsequent study by Sadowshi etal. (1977) 
demonstrated that it is the hydroquinone form of phylloquinone that is converted to the 2,3-
epoxide form, and O2 is the source of the epoxide oxygen. They concluded that the overall 
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reaction of epoxidation of phylloqinone seems to be catalyzed by a mixed-function oxidase, 
with the required reducing equivalent coming from the quinone form of vitamin K. 
Zimmerman and Matschiner (1974) reported that liver microsomes contain epoxide 
reductase activity that can convert the vitamin K-2.3-epoxide back to the vitamin, and this 
enz\'me is inhibited by warfarin. Whitlon et al. (1978) stated that this enzyme has very little 
activity in the presence of NAD(P)H but is very active when dithiothreitol is used as 
reducing agent. 
Tlie active form of K. vitamins is the hydroquinone form. Therefore, the regenerated 
quinone through the vitamin K-vitamin K-2,3 epoxide cycle and newly introduced dietary K 
vitamins need to be converted to KH2 form. There are several enzymes in animal tissues that 
can reduce K. vitamins to their hydroquinone forms (Olson. 1984). It was concluded by 
Wallin et al. (1978) that DT-diophorase (E.C. 1.6.99.2) is one of the physiologically relevant 
vitamin K. reductases. The enzyme is a flavoprotein that can use either NADH or NAD(P)H 
as CO factor and is inhibited by dicumarol (Emster et al.. I960; 1962). More recently, Wallin 
and Huston (1982) reported that only about 45% of the NAD(P)H activity of solublized 
microsomes could be neutralized by pure antibody against DT-diaphorase, and concluded 
that about half of the NAD(P)H dependent reductive activity is from a Warfarin-insensitive 
reductase that is different from DT-diophorase. Fasco and Principe (1980) showed that the 
hydroquinone of vitamin K resulted from the reduction of vitamin K by dithiothreitol in 
intact rat liver microsomes, and concluded that dithiothreitol might be another mechanism to 
reduce vitamin K to its KH2 form in the liver. The proposed vitamin K cycle is showed in 
Figure 1. 
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OH NAO(?) 
NAD(?)H 
FIGURE I. The proposed vitamin K-vitamin K-2.3-epoxide 
cycle (Olson. 1984. Ann. Rev. Nutr.) 
Difference Between the Avian and Mammal 
It is believed that the vitamin K requirement of chicks (0.5 mg/kg, NRC, 1994) is 5 to 
10 times that of rats (0.05 mg/kg. National Academy of Science. 1978) (Suttie, 1991). The 
metabolic basis for the high vitamin K requirement for chicks was studied by Will et al. 
(1992). These authors observed that one major difference between chicks and rats is that 
chick livers contain much higher MK-4 levels compared with those of rats when they were 
both fed the same diet. In rat liver. MK-4 was detected at a concentration of about ~10% of 
that of phyiloquinone. whereas in chick liver the concentration of MK-4 was more than twice 
that of phyiloquinone. Another major difference between the two species is that there is a 
very high level of phylloquino-2.3-epoxide in liver and plasma of chicks but not in rats, and 
the activity of vitamin K epoxide reductase is very low in chick liver, about 10% of that of 
rats. Based on these observations. Will et al. (1992) concluded that the inability of chicks to 
effectively recycle the epoxide of vitamin K seems to be the major factor related to its 
relatively high requirement of vitamin. 
Catabolism of K Vitamins 
The liver plays an exclusive role in the metabolic transformation of K vitamins that 
leads to their excretion from the body (Shearer et al. 1996). Wiss and Gloor (1966) reported 
that all K vitamins, in spite of differences in the quinone part and the side chains, are 
metabolized in the same way. The side chains are shortened to seven carbon atoms, yielding 
a carboxylic group that forms y-lactone. The major routes of excretion for K vitamin 
metabolites are bile and urine, of which the biliary route is quantitatively of greater 
significance than the urinary route (Shearer et al., 1974). Tracer experiments with labeled 
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phylloquinone have shown that a sizable fraction of a single dose of phylloquinone is rapidly 
metabolized and excreted. The fraction of the vitamin excreted was not dependent on the 
dose of administration (Shearer et al.. 1996). Shearer et al. (1974) reported that regardless of 
whether the ingested dose was I mg or 45 |4,g, ~20% was excreted in the urine within 3 days, 
whereas -40-50% was excreted via the bile in the feces. This extensive catabolism of 
phylloquinone by the liver is consistent with the observation of the rapid turnover and 
depletion of hepatic reserves in rats within a few hours after the removal of diets (Will and 
Suttie. 1992: Kinberg and Suttie. 1989). Shearer e/ al. (1996) stated that the body stores of 
phylloquinone are being constantly replenished. 
Functions of Vitamin K 
The Biochemical Basis for Functions of K Vitamins 
The major, if not only, function of K vitamins is to serve as an essential cofactor for 
vitamin K-dependent carboxylase that mediates the post-translational carboxylation of some 
specific glutamyl residues in nascent vitamin K-dependent proteins to y-carboxyglutamyl 
residues (Gla) in the corresponding mature proteins (Will et ai. 1992). The only known 
function of the Gla residues in all these proteins is binding to calcium ions (Knapen et ai, 
1993). The vitamin K-dependent carboxylation is shown in Figure 2. 
The exact mechanism of the vitamin K-dependent carbo.xylation remains unsettled. 
Olson (1984) stated that the generzd hypothesis for the action is: first, the carboxylase 
enzyme combines with the hydroquinone form of vitamin K (KH?) and Ot to yield a ternary 
enzyme-substrate complex and a possible vitamin KH2-(02) compound. The peptide that 
needs to be carboxylated. then binds to the complex. The metabolism of KH2-(02) to 
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Protein precursor Completed proteins 
CH2 Vitamin K CHrCOOH 
COOH COOH 
Glutamyl residue y-carboxyglutamyi residue 
FIGURE 2. The vitamin K-dependent carboxylation reaction 
vitamin K-2. 3-epoxide through an unknown intermediate(s) couples with the removal of the 
y-methyl proton from the specific glutamyl residues in the peptide and then carboxylation. 
The Gla residues in the vitamin K.-dependent proteins are essential for expression of 
their full biological activity (Will et ai, 1992). Therefore, the normal physiological functions 
of these Gla proteins are closely related to the vitamin K status of the animal, and the 
knowledge of these Gla protein physiological functions are really key to the understanding of 
the functions of vitamin K. 
Some of the Vitamin K-dependent Proteins and Their Functions 
From its discovery up to the early 1970s, vitamin K was thought to be needed only 
for the synthesis of four plasma clotting proteins in the liver, namely factors II (prothrombin), 
VII. IX and X. However, research during the past two decades has identified a whole list of 
Gla proteins in various of tissues that require vitamin K for their synthesis. Cells and tissues 
that actively synthesize Gla proteins include macrophages (Chapman, 1985), vascular 
endothelium (Stem et ai. 1986), kidney (Booth, 1997), uterine smooth muscle (Luo et al.. 
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1995). and bone (Hauschka and Reid. 1978). Cells of the chondrccytic lineage, such the ones 
in cartilage and trachea or bronchi, also actively synthesize Gla proteins (Luo et al., 1995). In 
most of these tissues, the Gla proteins have not been fiilly characterized. For example, very 
little is known about the Gla protein in kidney, nephrocalcin (Booth. 1997). Among all the 
Gla proteins identified only a few of them have been studied in some degree. These include 
the Gla proteins related to blood coagulation eg., factors II. VII. IX, X and proteins S and C, 
and those related to mineralization and remodelling of bone and/or calcification of some soft 
tissues, eg., osteocalcin. 
The four classical factors (11. VII. IX and X) in blood coagulation all exist in the 
forms of proenzymes in the circulation and they need to be activated to be functioned. 
Prothrombin, when activated, catalyzes a proteolytic reaction to cleave fibrinopeptides from 
fibrinogen, which converts fibrinogen to fibrin and results in the formation of a soft blood 
clot. Prothrombin is activated by activated factor X which in turn is activated through the 
intrinsic or extrinsic pathway of blood coagulation. One of the factors in the extrinsic 
pathway to activate factor X is factor VII. and the one in the intrinsic pathway to activate 
factor X is factor IX. Both factors VII and IX themselves need to be activated to be 
functional. The part of the blood clotting cascade related to Gla proteins is shown in Figure 3. 
It is clearly shown in the above figure that the conversion of prothrombin to thrombin 
is the key for the formation of blood clotting. Prothrombin sits at a cross point of the intrinsic 
and extrinsic pathways. The concentration of prothrombin in plasma is many times greater 
than the other three classic blood coagulation factors (X. IX. VII) (Olson, 1984). These facts 
make prothrombin an ideal protein to studying the function of vitamin K. There are several 
methods to determine the prothrombin concentration in plasma or the accumulation of its 
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Intrinsic pathway Extrinsic pathway 
Activation Activation 
IX • IXa. Vila < VII 
X Xa < X 
Prothrombin ^ Thrombin 
Fibrinogen ^ ^ Fibrin (soft clotting) 
FIGURE 3. Blood clotting cascade related to Gla proteins 
precursor protein in microsomes in livers. Shah et al. (1984) reported an amidolytic assay to 
determine the prothrombin concentration in plasma. Suttie (1973) reported that an 
accumulation of a precursor protein of prothrombin exists in the microsomes of warfarin-
treated or vitamin K-deficient rat livers. This accumulated microsomal precursor protein 
could be carboxylated by injection of vitamin K into anticoagulated rats, resulting its 
conversion to normal prothrombin and secretion into plasma-
Two other Gla proteins related to blood clotting and their functions are well-
documented are proteins S and C. Branson et al. (1983) reported that protein C inhibits 
coagulation and promotes tibrinolysis. Activated protein C can rapidly and selectively 
inactivate both normal and thrombin-modified factors V and VIII in vitro (Marlar et al, 
1982). Bahlback et al. ^"1986) reported that protein S plays an inhibitory role in blood 
coagulation by acting as a cofactor for activated protein C. 
One of the Gla proteins that is not related to blood clotting but has been intensively 
studied, is osteocalcin. Osteocalcin is an osteoblast-specific vitamin K-dependent protein that 
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is the most abundant of all the noncollagenous proteins found in bone matrix (Hauschka et 
al.. 1989). The expression of osteocalcin genes is regulated by vitamin D. Leeuwen et al. 
(1996) reported that 1. 25-(OH)2 D3 stimulated osteocalcin production in vitro in some 
osteoblastic cell lines such as ROS 17/2.8 or MG-63. Takede et al. (1994) postulated that the 
vitamin D receptor, which is a nuclear transcription factor, binds to the vitamin D response 
elements of the osteocalcin genes and regulates its expression. The biosynthesis and secretion 
of osteocalcin by the osteoblast is very similar to that of prothrombin by the hepatocytes. The 
transcriptive peptides need to be cleaved by the signal peptidase first, and then subjected to 
carboxylation at specific positions of glutamyl residues to form Glas (the total number of Gla 
residues in osteocalcin depends on species of animal.). Under the condition of vitamin K 
deficiency or in presence of warfarin, partial or no carboxylated osteocalcin may be formed 
(Hauschka et al.. 1989). The newly secreted osteocalcin might be released into blood 
circulation or deposited in bone matrix. Hauschka et al. (1989) stated that an estimated 90% 
or more of newly synthesized osteocalcin is deposited in bone matrix of 1-month-old rats, but 
as animals mature, a greater proportion of this protein is released directly into the blood 
circulation. 
The precise function of osteocalcin remains unsettled, but is assumed to be related to 
bone mineralization and remodeling (Hauschka et al., 1989). In vitro, osteocalcin binds 
strongly to hydroxyapatite cr>'stals. and is a potent inhibitor of hydroxy apatite formation 
(Price et al.. 1976). Stein et al. (1989) reported that cultured chick and rat osteoblasts 
produced low levels of alkaline phosphatase and osteocalcin until they reached confluence 
and a dense collagenous extracellular matrix accumulated. At this time, alkaline phosphatase 
activity increased, and osteocalcin synthesis was enhanced by 50- to 100-fold, coincident 
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with the onset of mineralization of the matrix. Lian et al. (1984) reported that the carboxy-
terminal part of osteocalcin possesses chemo-attractant activity for osteoclast progenitor cells 
that are involved in bone resorption. Ducy et al. (1996) reported that mice with the 
osteocalcin gene deleted were normal at birth. By 6-month of age, however, they developed 
long bones of increased thickness and density compared with wild-type mice, and had an 
increase in osteoclast surface and number. It was concluded that osteocalcin functions as a 
negative regulator of bone formation (Ducy et al. 1996). 
Matrix Gla protein (MGP). which is not related to blood coagulation, has been 
studied in some extent. Luo et al. (1995) reported that the MGP gene is predominantly 
expressed in cells of the chondroncytic lineage that either undergo endochondral ossification, 
such as the chondrocytes in the growth plate cartilage, or remain cartilaginouse, such as the 
chondrocytes in trachea or bronchi. The mRNA coding for MGP exists at very high levels in 
some soft tissues such as kidney, liver, and blood vessel walls (Fraser and Price, 1988). 
However, only trace amounts of immunoreactive MGP can be identified in these soft tissues, 
whereas it is abundant in bone and cartilage (Fraser and Price, 1988). The function of MGP 
remains a matter of speculation. Luo et al. (1997) reported that mice with a deleted MGP 
gene, were normal at birth compared with their wild-type littermates. However, the MGP-
deficient mice developed changes within two weeks after birth. These changes included 
increased heart rate, decreased stature, osteopenia, bone fracture, and ultimately death fi-om a 
rupture of the thoracic or abdominal aorta because of extensive calcification. The abnormal 
growth plate calcification was determined to be the cause of osteopenia and stunting. It was 
concluded that MGP inhibited the calcification of arteries and cartilage through its mineral-
binding ability (Luo et al.. 1997) 
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There is evidence that the various Gla proteins might differ in sensitivity to vitamin K 
deficiency or Warfarintreatment. Price (1989) reported that when young rats were given 
Warfarinand supplemental vitamin K concurrently, the concentrations of the Gla proteins 
related to blood coagulation remain unchanged, whereas osteocalcin concentration decreased 
by 98%. and MOP concentration decreased by 50%. The only observed abnormalities in 
these rats were excessive calcification of growth plate and nasal septum. 
Indications of Vitamin K Status 
Plasma Vitamin K Level and Liver Storage 
Level of Vitamin K in Plasma 
Booth et ctL (1995) concluded that plasma phylloquinone is a good biochemical 
measure of vitamin K status. Will and Suttie (1992) reported that plasma levels of 
phylloquinone or menaquinone-9 were closely related the concentrations of phylloquinone or 
MK-9 in diets that range from deficient to adequate. Suttie et at. (1988) instructed some 
college-aged male subjects to choose diets of low vitamin K. content to restrict the intake of 
vitamin K. and then phylloquinone supplementation was given to these subjects at the dosage 
of either 50 or 500 |xg/d. The phylloquinone intake of these subjects was decreased from 82 
|j.g/d during the prestudy period to 32-40 j4.g/d during the restriction period. Serum 
phylloquinone concentration decreased from 0.87 to 0.46 ng/ml. and the functionally active 
prothrombin ratio decreased from 10.024 to 0.911 as the phylloquinone intake decreased. 
Supplementation of 50 ^g phylloquinone per day increased serum phylloquinone firom 0.46 
to 0.56 ng/ml. and supplementation of 500|ig phylloquinone per day increased serum 
phylloquinone level furtlier to 10.6 ng/ml. Supplementation of 50 or 500 |j.g phylloquinone 
31 
per day increased the functionally active prothrombin ratio from 0.911 to 0.980 and 0.995, 
respectively. 
When plasma vitamin K. level is used as indicator of vitamin K status, there are 
several factors that need to be taken into account. First, the time period that animals are off 
feed when blood is collected. As mentioned in an early section ("Clearance of K vitzunins 
from plasma ") plasma FC vitamins are cleared very rapidly. The length of time that animals 
are off feed has great effect on the level of plasma vitamin K. Kindberg and Suttie (1989) 
reported that serum phylloquinone concentrations in rats that were fasted about 24 hours 
were independent of dietary concentrations of phylloquinone. Secondly, vitamin K in plasma 
is in close association with plasma triglyceride-rich lipoprotein (Sadowski et ai, 1989). 
Shearer ei al. (1992) reported that patients with various lipid disorders, especially those 
associated with hypertriglyceridemia, have very high plasma phylloquinone levels. Sadowski 
et al. (1989) reported that elderly adults had higher levels of phylloquinone in plasma than 
young adults. But. when the concentrations of phylloquinone were expressed as nmol 
phylloquinone per mmol of triglyceride, the elderly subjects showed decreased levels of 
phylloquinone compared with the young subjects. It is suggested that the ratio of plasma 
phylloquinone to plasma triglyceride would be a better index of vitamin K status than plasma 
phylloquinone alone under some of these conditions (Sadowski et al., 1989; Shearer et ai, 
1992). The last factor that needs to be considered is the genotype of apolipoprotein E. It has 
been shown that different variants of apolipoprotein E have great effect on the clearance rate 
of chylomicron remnants, and therefore, of plasma vitamin K. For details, see the section 
"Clearance of K. vitamins from plasma." 
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Concentration of vitamin K in the liver 
The liver is one of the major tissues that synthesize Gla proteins. The concentration of 
vitamin K in the liver, theretbre. has direct effect on the carboxylation of the specific 
glutamyl residues of the Gla proteins related to blood coagulation. Haroon and Hauschka 
(1983) reported that the normal range of phylloquinone in rat liver is between 4 and 44 ng/g 
fresh weight of liver. Taggart and Matschiner (1969) estimated that the minimum hepatic 
phylloquinone concentration needed to sustain normal prothrombin level in rats was 10 
pmol/g of fresh weight of liver. fCnauer (1976) reported that levels of vitamin BC in livers 
correlated with the eunounts of vitamin K fed to rats regardless of strain and sex difference. 
More recently. Will and Suttie (1992) confirmed the above observation. They observed that 
the concentrations of phylloquinone or menaquinone-9 in livers increased as the levels of 
phylloquinone or MK-9 in diets increased from 0.2 to 5.6 fj,moI/kg diets, respectively. 
Kindberg and Suttie (1989) reported that the liver concentrations of phylloquinone in rats fed 
a vitamin FC deficient diet with the addition of0, 10. 100. 500. or 1500 (4.g of phylloquinone 
/kg. was closely correlated to the amount of phylloquinone intake, and plasma prothrombin 
levels and one-stage prothrombin time all changed in a similar pattern as that of liver 
phylloquinone concentrations. 
Parameters Related to Blood Clotting 
The concentration of prothrombin in plasma and its degree of caboxylation 
Prothrombin is one of the Gla proteins that are synthesized by the liver, and is 
presenting the highest concentrations in plasma among all the Gla proteins related to blood 
coagulation. These characteristics make it an ideal subject for the study of vitamin K function 
and status. Under normal conditions, it is rare to identify undercarboxylated prothrombin in 
circulation. However, under the condition of vitamin K deficiency or Warfarintreatment, 
undercarboxylated prothrombin has been identified in many animal species including the 
chick, rat. mouse, hamster guinea pig, rabbit, and dog (Carlisle et ai, 1975). The 
prothrombin concentration in plasma can be determined by an amidolysis assay (Shah et ai, 
1984). The principle of the method is, briefly; plasma prothrombin is activated to thrombin 
with a physiological activation system to determine concentrations of normal prothrombin or 
with a specific snake venom to determine total prothrombin concentrations including the 
abnormal and undercarboxylated prothrombin. The formed thrombin catalyzes amidolysis of 
a specific chromogenic peptide substrate to release p-nitroaniline. The concentrations of p-
nitroaniline can be determined spectrophotometrically. Several tests to determine 
concentrations of decarboxylated-prothrombin are available including an electrophoresis 
immunofixation method, an immunoassay and the method to determine the absorbability to 
barium. The most sensitive method is based on monoclonal antibodies that specifically 
recognize decarboxy-prothrombin (Widdershoven. 1987). 
Shah et cil. (1987) reported that the concentrations of both plasma total and normal 
protlirombin in different strains of rats fed vitamin K deficient diets or treated with 
Warfarinwere significantly lower but undercarboxylated prothrombin levels were higher 
compared with that of vitamin K. sufficient rats. Kindberg and Suttie (1989) reported that 
plasma prothrombin level increased in rats as intake of phylloquinone increased. This is also 
true for menaquinones such as MK-9 (Will and Suttie, 1992). The difference between 
phylloquinone and MK-9 was that phylloquinone at low levels was much more potent for 
maintaining plasma prothrombin concentrations than MK-9 on an equimolar basis. 
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The concentration of the precursor of prothrombin in the liver 
Suttie (1973) reported an accumulation of a precursor protein in the liver microsomes 
of Warfarintreated or vitamin K-deficient rats. This accumulated preciursor protein could be 
carboxylated. resulting in conversion to prothrombin and secretion into plasma. Olson (1984) 
concluded that vitamin K.-deficient chicks accumulate only about 42% as much precursor 
protein per gram of liver as rats. Vitamin K. deficient rats given vitamin K show a marked 
"burst" of prothrombin secretion in the first hour, followed by a slower rate of plasma 
enrichment (Suttie. 1970: Bell and Matschiner. 1969). Vitamin K.-deficient chicks, however, 
show a linear response in prothrombin secretion upon receiving a vitamin K source (Olson et 
ai, 1968) 
Esmon et al. (1975) reported that the concentration of accumulated precursor protein 
of prothrombin in liver is determined by a vitamin K-dependent in vitro carboxylase system. 
The undercarboxylated precursor protein is carboyxlated in the system. The carboxylation 
leads to incorporate of '"*€ from NaH'^C03 into the precursor protein. Radioactivity is 
determined and the concentration of the precursor protein calculated. 
Will and Suttie (1992) reported that the concentrations of the liver microsomal 
vitamin K.-dependent precursor protein in rats decreased as the intake of phylloquinone 
increased. Tliis is consistent with an earlier report by BCindberg and Suttie (1989). 
Activity of vitamin K-dependent carboxylase in the liver 
The microsomal vitamin EC-dependent carboxylase in liver is one of the enzymes that 
require vitamin K as an essential cofactor. Its activity, therefore, is closely related to the 
status of vitamin K. Suttie and Hageman (1976) reported that the vitamin K-dependent 
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carboxylase activity in liver can be determined through the assay of '''C incorporation into a 
synthetic peptide. The basic principle of the method is: the vitamin K-dependent carboxylase 
is solubilized by treatment with Triton 100. The soluble fraction is incubated with an energy-
generating system. NaH'"*C03. a synthetic peptide, and vitamin K to initiate the reaction. The 
synthetic peptide is cabo.xylated with radioactive '''C, and is isolated. Radioactivity is 
determined and used to calculate the activity of the carboxylase activity. BCindberg and Suttie 
(1989) reported that the peptide carboxylase activity in rat liver decreased from 7966, 5158, 
4135 to 2613 dpm/mg protein as intake of phylloquinone increased from 10, 100, 500 to 
1500 i-ig/kg diet. This observation indicated that there were more molecules of vitamin K-
dependent carboxylase in vitamin K deficient rat liver than in vitamin K adequate one. 
Prothrombin time 
Prothrombin time determined by the one-stage method developed by Quick (1935) or 
the two-stage method developed by Warner et al. (1936). is widely used to evaluate vitamin 
fC status of animals and humans. With the availability of some commercial kits it is handy to 
determine the status of vitamin K or factors in the extrinsic blood coagulation pathway by 
these methods. However, it must be noted that the assumption made in the prothrombin time 
method is that when an excess amount of thromboplastin in the form of a potent tissue extract 
is added to recalcified plasma, the formation of thrombin is regarded as a direct function of 
the concentration of prothrombin. As Quick (1959) stated "when the test was developed, 
thromboplastin and prothrombin were accepted as the two basic agents needed for the 
generation of tlirombin ... ." It is clear now that there are many more factors than 
thromboplastin and prothrombin involved in the conversion of prothrombin to thrombin. 
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Therefore, a prolonged prothrombin time would not exclusively denote a decrease of 
prothrombin. Kindberg and Suttie (1989) stated that one-stage prothrombin time is less 
sensitive to the status of vitamin K, compared with other methods such as plasma 
prothrombin level. Suttie et al. (1988) reported that when phylloquinone intake of college-
aged male subjects decreased from 82 to 32-40 jig/day. the prothrombin times were all in the 
normal range. However, serum phylloquinone concentration decreased from 0.87 to 0.46 
ng/ml. and functionally active prothrombin ratio decreased from 1.024 to 0.911. 
Nevertheless, prothrombin time provides some basic information of vitamin K status, and it 
is cheap, easy and simple. 
Parameters Related to Bone 
Osteocalcin level in plasma and its degree of carboxylation 
Knapen et al. (1989) reported that in a selected group of postmenopausal women the 
hydroxy apatite binding capacity of the circulating immunoreactive osteocalcin (irOC) was 
abnormally low compared with premenopause women. Administration of vitamin K (1 
mg/day) increased both the concentration and the hydroxyapatite binding capacity of 
circulating irOC. In a subsequent study, Knapen et al. (1993) showed that the increase of 
circulating irOC caused by the supplementation of vitamin K in elderly women was due to 
the increased level of serum irOC with a high affinity for hydroxyapatite, whereas the level 
of irOC with a low affinity remained unaffected even after supplementation of vitamin K for 
3 months. This raises the question of whether irOC w^ith low affinity for hydroxyapatite has a 
physiological role and whether its secretion is regulated by the osteoblast. It is postulated that 
irOC with a low affinity for hydroxyapatite might be involved in bone resorption (Knapen et 
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al.. 1993) by serving as a chemoattractant for osteoclast-like cells (Vermeer et al., 1996). 
More recently. Joe et al. (1995) reported that an impaired vitamin K status, as reflected by a 
low nutritional vitamin K intake, was accompanied by an increased irOC level and a reduced 
hydroxyapatite binding capacity of circulating osteocalcin in women with atherosclerosis. 
Gla concentration in bone 
Hauschka and Reid (1978) reported that the Gla concentration in pooled tibiotarsus 
and femur diaphysis was reduced to about 47% of the level of control chick embryos of 19 
day when embryos were injected Warfarintwice at the dosage of 2.0 mg/kg egg at 13 and 16 
days if incubation. Gla concentrations in different types of bones (including long bone, 
mandible, and calvaria) of 3-week-old chicks fed vitamin K. deficient or dicoumarol 
containing diets, were about 56-59. and 27-36% of the level of the control chicks, 
respectively. However, the extent of change of the Gla concentration in bone was not strictly 
parallel to that observed for prothrombin time (Hauschka and Reid. 1978). More recently, 
Lavalle el al. (1994) similarly observed that a deficiency of vitamin K significantly decreased 
Gla concentration in bones of chicken embryo and growing chicks. The decrease in Gla 
concentration in bone, however, was not associated with any gross or histological change in 
bones (Hauschka and Reid. 1978; Lavalle et al. 1994). Shearer (1995) stated that the pattern 
of healing and the final structure and strength of repaired bone in animals seem to be normal 
even with a reduction of osteocalcin in bone to 2% of normal concentration. 
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Gla Excretion in Urine 
Once Gla has been formed it is not metabolized or re-used. So eventually all Gla is 
excreted via the urine, most in a free amino acid form and less than 5% in a peptide-bound 
form (Shah et al.. 1978). Hence, urinary Gla level reflects the turnover of total body pool of 
Gla proteins. Under a steady state, the urinary excretion of Gla is a measure for the total 
production of Gla that is essentially dependent on the vitamin K status (Cracium et aL, 1997). 
Suttie et al. (1988) reported that dietary vitamin K restriction in college-aged male subjects 
resulted in a decrease in urinary y-carboxyglutamic acid. When phylloquinone intake was 
reduced from 82 j.ig/d to 32 to 40 fxg/d, urinary Gla excretion in these college-aged subjects 
decreased to 78% of the normal values. Supplementation with 50 or 500 jig of phylloquinone 
per day restored Gla excretion to normal values. However. Booth et al. (1995) reported that 
dietary intake of phylloquinone was not correlated with urinary Gla excretion in 
postmenopausal women. Ferland et at. (1993) also reported that elderly subjects did not 
demonstrate any changes in their urinary Gla levels when consuming a low phylloquinone 
diet, whereas young subjects did. Booth et al. (1995) indicated that there might be changes in 
vitamin K. metabolism associated with aging which have an impact on urinary Gla levels. 
Using rats as a model. Cracium et al. (1997) studied the influence of vitamin K on the 
urinar\' excretion. Supplementation of extra vitamin EC orally in the form of phylloquinone or 
MK-4 to rats (12-week-old) fed a reference diet that had been proven to be vitamin K 
sufficient by prothrombin time, increased urinary Gla excretion substantially. This indicated 
that the vitamin K. requirement for liver and extrahepatic tissues might be different. However, 
when MK-8 was supplemented to these rats, no increase in Gla excretion was observed. 
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which raises the question of the bioavailibility of menaquinones with long side chains, such 
as MK-8. for extrahepatic tissues. Cracium et al. (1997) also observed that the Gla excretion 
in urine was decreased when rats were fed a vitamin tC-deficient diet or when the rats were 
treated with coumarin. 
Biological Activity of Different K Vitamins 
Biological Activity of Vitamin K 
Vitamin K is a general term for a series of related compounds which all have a 
naphthoquinone ring. It includes phylloquinone. menaquinones and synthetic menaquinone 
derivatives. 
Natural phylloquinone from plant sources occurs entirely as a trans-isomer that is 
fully potent (Knauer et. al. 1975). However, synthetic phylloquinone contains a mixture of 
the both cis- and trans- isomers. Matschiner and Bell (1972) reported that although the 
distribution and turnover of cis-phylloquinone in liver subcellular fractions were similar to 
that observed with trans-phylloquinone. cis-phylloquinone had little or no biological activity. 
These authors indicated that most of the administered cis-phylloqinone might not be bound to 
an active site. In a subsequent study with rats. Knauer et al. (1975) showed that the cis-
isomer of phylloquinone was a poor substrate for 2,3-epoxidation both in vivo and in vitro. 
Menaquinones are a series of related compounds with various numbers of iospreniod 
residues at the three position of naphthoquinone. The number of isoprenoid units of the side 
chains has a great effect on the biological activity of menaquinone series. Some of the 
biological activities reported in literature are summarized in Table 5. 
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TABLE 5. Relative biological activity^ of menaquinones (vitamin K2) 
Vitamin K2 Matchiner and Doisy (1966) Wiss et. al (1959) and Weber & Wiss (1959) 
% 
MK-l I -15 
MK-2 35 -40 
MK-3 — 100 
MK-4 100 -120 
MK-5 156 100 
MK-6 — -70 
MK-7 122 — 
MK-9 67-78 — 
MK-IO 49 
' The biological activity of vitamin K.1 was assigned to be 100. 
More recently. Akiyama et al. (1995) reported that among all the vitamin K2 
analogues (MK-l to 14). MK-4, -5. and -6 had the highest vitamin K activity as measured by 
the sustenance of coagulation activity and plasma prothrombin levels. MK-7 and MK-8 also 
had substantial vitamin K activity. However, blood coagulation activity and prothrombin 
level were not improved in rats fed a vitamin K-deficient diet and treated with Warfarinwhen 
supplemented with MKs with 9, 10 or 11 isoprene units. This observation is contrary to some 
other reports showing MKs with long side chziins, such as MK-9, had viteimin K activity and 
were equally as or more potent than phylloquinone. Will and Suttie (1992) reported that MK-
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9 was equally effective at a higher level (>1.I pmol/kg diet) as phylloquinone to maintain the 
plasma prothrombin levels and the liver microsomal vitamin-K dependent protein precursor 
levels in rats when supplemented in a vitamin K-deficient diet. Groenen —van Dooren et al. 
(1995) reported that MK-9 was 50 to 80% more potent than phylloquinone for maintaining a 
satisfactor\' plasma prothrombin level when administered orally or subcutaneously 10 
nmol/day to rats fed a vitamin K deficient diet. This observation was confirmed by 
Matschiner and Taggart (1964) who reported that MK-9 was more potent than phylloquinone 
for maintaining prothrombin level when administered by intracardial injection. The 
discrepancy in the biological activity of MK-9 and perhaps other MKs with long side chains, 
might be explained by the difference of dosage administered, the animal models used, and 
the time of sampling after the administration. Will and Suttie (1992) reported that the plasma 
prothrombin concentration of rats fed a diet containing low level of MK-9 (0.2 |i.mol/kg diet) 
was similar to those of rats fed a vitamin K-deficient diet whereas the prothrombin 
concentrations of rats fed a high level of MK-9 (1.1 |j,mol or more/kg diet) was similar to 
those of rats fed on equal molar of phylloquinone. This observation demonstrates that MK-9 
is an equally potent vitamin K source as phylloquinone at high levels but not at a low level. 
Groenen-van Dooren ct al. (1995) stated that when vitamin K-deficient animals are used to 
determine the biological activities of K vitamins, the vitamin cycle is operational, therefore, 
substantial vitamin K is recycled via vitamin-K epoxide reductase. However, when 
Warfarintreated animals are used for the same purpose, the reduction of vitamin K is only via 
the NADH-dependent pathway because of the blockage of the epoxide reductase pathway. 
This difference in recylcing vitamin K under the two different animal model systems might 
influence the biological activity of vitamin K. Akiyama et al (1995) reported that MK-9 
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alleviated tiypoprothrombinaemia within 24 hours but not within 4 hours after administration 
and concluded that the length of isoprene units of menaquinones affects the time needed for 
them to exert vitamin K activity. 
The biological activity of menaquinone series is also affected by geometric 
isomerization. W'iss et al (1959) and Weber and Wiss (1959) reported that the biological 
activity of MK-3 all trans form was 86% of that of phylloquinone whereas the values for 6.7-
mono-cis and 10, 11-mono-cis of MK-3 were 118 and 85% of that of phylloquinone. The 
biological activity of different geometric isomers of MK-5 is different, too. Wiss et al (1959) 
reported that the biological activity of all trans. 6,7-mono-cis. and 18, 19-mono-cis isomers 
of MK-5 were 58, 133 and 52%. respectively, of that of phylloquinone. 
Biological Activities of Menadione Analogues 
The comparison of biological activities among menadione derivatives or between 
menadione derivatives to other K vitamins should be on molar basis, and any comparison 
that is not on this basis should be converted to a molar basis. The molecular weight of 
vitamin KI is 451 daltons, and the analogue values for menadione, menadione sodium 
bisulfite, menadione dimethylpyrimidinol bisulfite, menadione nicotinamide bisulfite are 
172, 276. 378, and 376 daltons, respectively. 
Menadione is a fat-soluble crystalline compound. Quick and Stefanini (1957) 
reported that menadione was slightly less effective than vitamin Kl as a vitamin K source on 
a molar basis. Nelson and Norris (I960) reported that the required amount of menadione to 
maintain normal prothrombin time was 1.03 to 1.68 times the amount of vitamin Kl needed. 
This indicated that the potency of menadione as a vitamin K source was about 60-97% of that 
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of vitamin K.I. However, other results show that the potency of menadione as a vitamin K 
source is less than tliat suggested by the above values. Griminger and Donis (1960) reported 
that vitamin Kl was 2.5 times as active as menadione on a molar basis for decreasing 
prothrombin time of vitamin K.-deficient chicks to normal. They also observed that, in 
comparison with vitamin Kl. eight times as much as menadione was needed to minimize 
prothrombin time of chicks fed diets containing dicumarol or sulfaquinoxline. Matschiner 
and Diosy {1966) reported that the potency of menadione was only 49% that of 
phylloquinone. 
The wide variation in biological activity of menadione might be related to a 
difference of absorption. Nelson and Norris (I960) stated that menadione, a fat-soluble 
crystalline compound, is less readily absorbed than oil-like vitamin K.1 or water-soluble 
menadione derivatives. And because menadione is a crystalline compound, it can't be 
assumed that the same proportion goes into solution in dietary fats and is absorbed to the 
same extent in each experiment. For instance. Shelton et al. (1956) obtained different dietary 
requirements of menadione at different dietary fat levels. The observation of Fisher et al. 
(1956) that when injected intravenously, vitamin Kl and menadione had approximately the 
same molar biological activity, provided indirect support for the argument that the difference 
between biological activities of vitamin Kl and menadione might be related a difference of 
absorption. 
Menadione sodium bisulfite is one of the water-soluble forms of menadione 
analogues. Its biological activity has been shown to be approximately the same as vitamin Kl 
on a molar basis (Nelson and Norris, 1960). However, Griminger and Donis (1960) reported 
that the biological activity of menadione sodium bisulfite was only about 60% of that of 
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vitamin Kl. Several researchers have shown that the biological activity of menadione sodium 
bisulfite is definitely greater than that of menadione (Frost and Spruth, 1955; Frost et al 
1954; Shelton et al 1956; Nelson and Norris, 1960; Griminger and Donis, 1960). However, 
the reported quantitative ratio of biological activity of menadione sodium bisulfite to 
menadione on molar basis varied considerably. Griminger and Donis (1960) reported that 
biological activity ratio of menadione sodium bisulfite to menadione was 1.7, and the ratios 
reported by Nelson and Norris (1960) varied from 1.3 to 1.8. Other research results indicate a 
much higher ratio. Frost and Spruth (1955) reported that biological activity ratio of 
menadione sodium bisulfite to menadione was 4, and Shelton et al. (1956) reported that the 
value was 18. This huge variation of ratio of biological activity of menadione sodium 
bisulfite to menadione perhaps is related to the variation of determined biological activity of 
menadione whereas the biological activity of. menadione sodium bisulfite is relatively 
consitent. 
Menadione dimethylpyrimidinol bisulfite is another water-soluble form of mendione 
derivatives. Griminger (1965) concluded that the vitamin K potency of menadione 
dimethylpyrimidinol bisulfite was greater than that of menadione sodiimi bisulfite. The 
conclusion was based on the observation that the amount of menadione sodium bisulfite 
required to obtain a short prothrombin time was 1.8 times the amoimt of menadione 
dimethylpyrimidinol bisulfite, whereas the ratio should be 1.36 if the potency of both these 
two compounds were same on a molar basis. These results were confirmed by Dua and Day 
(1966). 
Recently, a new source of menaquinone analogue, menadione nicotinamide bisulfite 
has become available. Oduho et al (1994) compared the vitamin K activity of this new source 
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with that of menadione dimethylpjriniidinol bisulfite, and concluded that these two 
compounds were equally potent as vitamin K source on molar basis. Menadione 
nicotinamide bisulfite, however, is an effective source of niacin, too. Menadione 
nicotinamide bisulfite contains about 32% of nicotinamide on weight basis. 
Vitamin K Requirement of Poultry 
Creation of Vitamin K Deficiency in Animal Model System 
Experimentally-induced vitamin K deficiency must be created in animals to facilitate 
research designed to determine dietary vitamin K requirements, obtain information on the 
biopotency of dietary vitamin K sources, and determine the influence of various factors on 
the vitamin K requirement. There are two strategies to create a vitamin K-deficiency in 
animals. One is to reduce oral intake of vitamin K. and to suppress the synthesis of vitamin K 
in the intestinal tract. Another is supplementation of vitamin K. antagonists such as 
Warfarinor dicumarol. Both of these strategies have been used in experiments. 
The vitamin FC requirement of animals is met by a combination supply fi-om dietary 
source and from the microbial biosynthesis in the intestinal tract. The vitamin K synthesized 
in the intestinal tract may be absorbed directly or through ingestion of feces (coprophagy). 
Vitamin K-deficient diets 
To fully induce a vitamin K deficiency in animals, they must be fed a diet devoid of 
or very low in vitamin K. For studies with rats, vitamin K-deficient semi-purified or purified 
diets are most commonly used. These diets consist mostly of casein or soybean protein as 
protein sources, and com starch, sucrose or glucose as energy sources. Mathers et al. (1990) 
successfully developed another semi-purified, vitamin K-deficient diet that was composed of 
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primarily rice and casein. About 23 days were required to develop signs of vitamin K 
deficiency using this type of diet compared with about 5 to 7 days when purified diets were 
used (Vermeer. et al. 1995). The form and storage conditions of diets also affect the time 
needed to develop vitamin IC-deficiency. Vermeer et al. (1995) stated that powdered feed 
may be hygroscopic, and if such a feed is kept at room temperature for more than one week, 
menaquinone-producing bacteria may develop and thus reduce the effectiveness of the diet 
Compared with rats, vitamin K deficiency is more easily developed in poultry, simply by 
dietary restriction of the vitamin. The common com-soybean meal type diet has been used to 
successfully develop vitamin K deficiency in chicks (Frost et ai, 1956) and turkeys 
(Griminger. 1957). Semi-purified diets with soybean meal as a protein source, and purified 
diets have also been used to develop vitamin K deficiency in poultry. When formulating 
diets, special attention should be given to the sources of fat in diets. The fat sources used are 
usually stripped or refined to reduce the concentration of vitamin K. Examples of special fat 
sources used include stripped lard (Nelson and Norris, 1960) and stripped com oil 
(Griminger and Donis. 1960). Occasionally com oil is used (Oduho et al., 1993; Mathers, 
1990) 
Suppression of microbial synthesis of vitamin Kand prevention of ingestion of feces 
The microbial flora in the intestinal tract can synthesize vitamin K. and this vitamin K 
may be absorbed by the host animals fi-om the ileum (Conly. 1992). Therefore, the microbial 
population in the intestinal tract should be suppressed to reduce the production of vitamin K 
if a vitamin K deficiency is wanted. Broad-spectrum antibiotics such as neomycin and sulfa 
drugs can be used for this purpose. These drugs are capable of essentially sterilizing the 
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intestinal tract and inducing hemorrhagic syndrome (Vermeer et al., 1995). Sulfa drugs such 
as sulfaquinoxaline have been shown to interfere with the metabolism of vitamin K and 
increase the requirement of vitamin K dramatically (Frost et al., 1956; Frost and Spruth, 
1955). This is due to the fact that sulfamides inhibit the capacity of liver to produce 
prothrombin (Black et al.. 1942: Mushett and Seeler, 1947). 
Under normal conditions, rats eat their feces. Bames et al. (1957) observed that rats 
maintained on raised wire screen still ingest 50 to 65% of their feces. This problem can be 
overcome in two ways. First, one may use germ-free rats. However, maintaining animals 
under sterile condition presents practical problems, especially when the experiments extend 
over long period of time and repeated handing of the animals is required. Alternatively, feces 
can be collected in anal cups. In chicks and turkeys, simply keeping them on wire floors and 
cleaning feces often enough to keep it out of reach is enough to eliminate the ingestion of 
vitamin K from fecal materials. 
The vitamin K antagonist regimes 
In early studies vitamin K. antagonists such as Warfarinand dicumarol were often 
employed to create vitamin K. deficiency because of the difficulty of creating of a consistent 
vitamin K deficiency with special diets. This was especially true in rats. Nowadays, vitamin 
K-deficient diets are easily created with the availability of ingredients containing low levels 
of vitamin K. and vitamin K antagonist regimes are not used very often except in some 
special research. 
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Vitamin K Requirement of Chicks 
Using the minimum prothrombin time as the criterion, Griminger and Denis (1960) 
reported that the vitamin K1 requirement of chicks fed a purified diet containing 1% of 
refined com oil was I mg/kg diet. Nelson and Norris (1958) estimated the requirement of 
vitamin fCI for chicks varied from 0.4 to 0.6 mg/kg diet. This latter observation was 
conllrmed by Nelson and Norris (I960), who reported that the vitamin K1 requirement of 
chicks at 2 and 4 weeks of age were 0.524 and 0.528 mg/kg diets, respectively. 
Shelton et al. (1956) reported that the menadione requirement of chicks was about 
1.19 mg/kg diet when the diet was supplemented with 5.7% fat, whereas the requirement 
increased to 1.39 mg/kg diet when supplemental fat levels decreased to 2.7%. Griminger and 
Donis (1960) reported that 1.15 mg menadione /kg diet was needed to achieve a minimum 
prothrombin time. Nelson and Norris (1960) reported that the menadione requirement of 
chicks could var\' from 0.205 to 0.970 mg/kg diet. However. Frost et al. (1956) reported a 
much higher requirement of menadione for chicks. These authors observed that menadione, 
even at a high level such as 2.88 mg/kg diet, could not bring prothrombin time back to 
normal level. 
Frost and Spruth (1955) reported that a dietary concentration of menadione sodiimi 
bisulfite from 34 to 45 ug/kg only provided partial protection against hemorrhagic condition. 
For fiill protection. 90 to 180 |j.g menadione sodium bisulfite /kg diet was needed. Nelson and 
Norris (1960) reported that the menadione sodium bisulfite requirement of chicks at 2 and 4 
weeks of age varied from 0.254 to 0.356 and 0.320 to 0.373 mg/kg diet, respectively. Shelton 
el al. (1956) reported tliat the menadione sodium bisulfite requirement of chicks was 0.198 
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mg/kg diet, regardless of the level of fat in the diet. However, other researchers showed that 
the menadione sodium bisulfite requirement was much higher. Griminger and Donis (1960) 
estimated that, to achieve a minimum prothrombin time, 0.96 mg menadione sodiiun 
bisulfite/kg diet was required by chicks. Frost er al. (1956) observed that whole blood 
clotting time of chicks plotted against the log of the concentrations of menadione sodium 
bisulfite in diets gave a straight line in the range of0.045 to 0.72 mg/kg diet, indicating that 
0.72 mg menadione sodium bisulfite/kg diet might not meet the requirement. 
The requirement of the two other menadione analogues, menadoine 
dimethylprimidinol bisulfite and menadione nicotinamide bisulfite, have not been well 
studied. Oduho et al. (1994) reported that prothrombin time of chicks fed diets containing 0 
to 0.4 mg menadione /kg diet from menadoine dimethylprimidinol bisulfite or menadione 
nicotinamide bisulfite decreased linearly, but no estimate of requirement was made. 
Although it has been well documented that vitamin K is required for the post-
trascription carboxylation of some glutamic acids in Gla proteins in bone to form osteocalcin 
or matrix Gla protein, the effect of vitamin K on bone is not conclusive. Lavelle et al. (1994) 
reported that vitamin K-deficient chicks and chick embryos developed normal skeletal 
structure on the basis of gross and histological morphology and bone ash, even though they 
exhibited a severe reduction in prothrombin time and bone Gla concentration when compared 
to control chicks. Fleming et al. (1998) reported that the cancellous bone volume loss in the 
proximal tarsometatarsus was significantly reduced in laying hen from 15 to 25 weeks of age 
when these hens were fed on a diet supplemented with 10 mg menadione /kg diet compared 
to control hens that were fed on a diet containing 2 mg menadione /kg diet. 
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The Vitamin K Requirement of Turkeys 
Compared with chicks, literature on vitamin K requirement of turkeys is scarce. 
Griminger (1957) reported that the menadione sodium bisulfite requirement was 1.1 mg/kg 
diet based on prothrombin time, whereas the menadione requirement was 1.76 mg/kg diet. 
There is no information available in the literature on the vitamin K.I requirement of turkeys. 
Some Nutrients, and Additives that Influence the Dietary Requirement of Vitamin K 
The requirement of vitamin K has been shown to be influenced by several nutrients, 
most notably fat and fat-soluble vitamins such as vitamins A and E. Shelton et ai, (1956) 
reported that the requirement of menadione of young chicks was affected by dietary fat 
levels. When the fat level was 5.7%. the requirement of menadione was 1.19 mg/kg, whereas 
when dietJiry fat level was reduced to 2.7% the requirement increased to 1.39 mg/kg. These 
authors, however, observed that the requirement of water-soluble form of menadione 
derivatives such as menadione sodium bisulfite was not affected by dietary fat levels. 
It has long been known that fat-soluble vitamin A antagonizes vitamin K in rats. 
Light et cil. (1944) reported that hypervitaminosis A in rats leads to hemorrhagic syndrome 
and hypoprothrombinemia that can be prevented by the administration of vitamin BC. 
Matschiner and Diosy (1962) observed a relationship between greater than normal levels of 
dietary vitamin A and resulting deficiency of vitamin K as indicated by the depression of 
plasma prothrombin levels in rats. These authors also observed that retinoic acid was more 
effective than vitamin A acetate as an antagonist of vitamin K. In a subsequent study, 
Matschiner et cil. (1967) observed that giving 50 lU retinoic acid per day to rats increased the 
requirement of vitamin K. to 10 times that seen in germ-free rats. It was concluded that excess 
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vitamin A antagonizes vitamin K during the process of absorption (Matschiner et al. 1967). 
In chicks, however. Abawi and Sullivan (1989) failed to observe any interaction between 
vitamin A and vitamin K on body weight, feed efficiency and plasma vitamin A level in an 
experiment with factorial arrangement of the two vitamins at the levels representing 
deficient, optimum and excess. But they did not determine the plasma prothrombin time or 
other parameters related to vitamin K status. 
Large amounts of dietary vitamin E also antagonize the action of vitamin K. Olson 
and Jones (1979. 1984) observed that a high dietary intake of vitamin E by rats antagonizes 
vitamin K activity and increases the requirement of vitamin K. March et al. (1973) reported 
that, when diets containing 2200 lU vitamin E per kg diet were fed to chicks, prothrombin 
times were lengthened. At a relatively low level of vitamin E (100 lU), however, Abawi and 
Sullivan (1989) failed to observe any negative effect on the performance of broiler chicks 
even when they were fed on a low vitamin K (0.22 mg menadione sodium bisulfite/kg) diet. 
Prolongation of prothrombin times as a result of megavitamin E therapy also has been 
reported in humans (Korsan-Bengsten e/a/.. 1974). 
The nature and mechanism of the antagonism between a-tocopherol and vitamin K 
remains unsettled, but there is some evidence indicating that the antagonism might be at the 
level of metabolism rather than at the level of absorption. Wooley (1944) first observed that 
a-tocopherolquinone in large doses caused hemorrhages in rats that were prevented by 
menadione supplementation. These observations were confirmed with pregnant rats by Rao 
and Mason (1975). Bettger and Olson (1982) reported that d-a-tocopherolquinone was a 
more potent antagonist of vitamin K activity in rats than d-a-tocopherol. Neither compound 
seemed to affect the absorption and distribution of vitamin K in the body. These authors also 
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observed that feeding high levels of vitamin E to rats (2 g/kg diet) resulted in an increase in 
d-a-tocopherolquinone in liver microsomes from 2.5 to 9.4 nmol/g. 
There are several feed additives that have been shown to influence the requirement of 
vitamin K. One group of such additives includes broad-spectrum antibiotics such as 
neomycin. Tliese antibiotics suppress or completely inhibit vitamin K sjoithesis by the 
microbial flora in the intestinal tract. Hence, supplementation of such antibiotics in diets 
might increase the requirement of vitamin K.. Another compound that influences the 
requirement of vitamin K. is the antioxidant, butylated hydroxytoluene (BHT). Takahashi and 
Hiraga (1978a) reported that BHT causes a high incidence of death due to massive 
hemorrhages when included in the diets of rats at concentrations of 0.69% or more. Further 
investigation showed that a significant dose-dependent reduction in plasma prothrombin time 
could be detected when the low concentration of BHT in the diet was only 0.017% 
(Takahashi and Hiraga. 1978b). Supplementation of vitamin K deficiency prevented the 
BHT-induced hypothrombinaemia. implying that vitamin K was directly or indirectly 
involved in the hemorrhagic death caused by BHT. More recently. Cottrell et al. (1994) 
reported that BHT induced clotting factor defects in vitamin K-sufficient rats, and the defects 
could be corrected by further supplementation of vitamin K. These authors, however, 
reported that no clotting factor defects were induced at a dose level of 125 mg BHT /kg body 
weight, and concluded that BHT was unlikely to be a human safety problem because it 
produced no clotting factor defect in rats receiving an intake of 1000 times the acceptable 
daily intake by humans. 
The mechanism by which BHT antagonizes the function of vitamin K is believed to 
be similar to that of coumarin (Suzuki et al., 1983). Suzuki et al. (1983) reported that the 
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vitamin K contents of the livers of rats fed diets containing 0.25% of BHT were reduced, and 
fecal excretion of vitamin K. metabolites was increased compared vsdth control rats. It has 
been shown that BHT needed to be activated to exert its hemorrhagic effect. Takahashi and 
Hiraga (1981) reported that quinone methide. a metabolite of BHT, inhibits vitamin K 
epoxide reductase activity by 20 to 30% in rats. This mechanism was further confirmed by 
Takahashi (1987) who reported that BHT quinone methide seems to be more potent than its 
parent compound to cause reductions in clotting factors 11. VII. IX and X. 
References 
Akiyama. Y.. Kuniko Hara, Akira Matsumoto, Sumiko Takahashi and Tetsuya Tajima, 1995. 
Comparison of intestinal absorption of vitamin K2 (menaquinone) homologues and 
their effects on blood coagulation in rats with hypoprothrombinaemia. Biochemical 
Pharmacology Vol. 49. No. 12:1801-1807. 
Aliquist. H. J.. 1952. Relation of prothrombin level to vitamin K intake. Arch. Biochem. 
Biophys 35:463 
Barnes, R. H.. G. Fiala. B. McGehee. A. Brown, 1957. Prevention of coprophage in the rat. 
J. Nutrition 63: 145-153. 
Bell. R. G-. J. T. Matschiner. 1969. Intracellular distribution of vitamin K in the rat. Biochim. 
Biophys. Acta 184:597-603 
Bell. R. G.. J. T. Matschiner. 1969. Synthesis and destruction of prothrombin in the rat 
Biochem. Biophys. Acta 184:473-476. 
Bettger. W. J.. R. E. Olson. 1982. Effect of a-tocopherol and a-tocopherol-quinone on 
vitamin K-dependent carboxylation in the rat. Fd. Proc. 41: 344. 
Bjomsson. T. D. P. J. Meffin. S. E. Swezey, T. F. Blaschke. 1979. Effect of ciofibrate and 
Warfarinalone and in combination on the disposition of vitamin Kl. J. Pharmacol. 
Exp. Ther. 201:322-26 
Bjomsson, T. D. P. J. Meffin. S. E. Swezey, T. F. Blaschke, 1980. Disposition and turnover 
of vitamin Kl in man. In Vitamin K metabolism and Vitamin K-dependent proteins. 
Ed. Suttie. J. VV. Pages 328-332. Baltomore: Unveristy park press. 
Booth- S. L.. J. A. T. Pennington, and J. A. Sadoski, 1996. Dihydro-vitamin kl: primary 
source and estimated dietary intakes in the american diet. Lipids Vol. 31, No. 7:715-
720 
Booth. S. L.. 1997. Skeletal function of vitamin K-dependent proteins: not just for clotting 
any more. Nutrition Reviews 55: 282-284. 
Booth. S. L.. J. A. Sadowski. and J. A. T. Penington, 1995. Phylloquinone(Vitamin Kl) 
content of foods in the U. S. food and drug administration's total diet study. J. Agri. 
Food Chem. 43:1574-1579. 
Booth. S. L.. J. A. Sadowskt. and J. L. Weihrauch, and Guylaine Ferland, 1993. Vitamin Kl 
(phylloquinone) content of foods: A provisional table. J. Food Composition and 
Analysis 6:109-120. 
Booth. S. L.. K. W. Davidson. A. H. Lichtenstein, and J. A. Sadowski, 1996. Plasma 
concentrations of dihydro-vitamin kl following dietary intake of a hydrogenated 
vitamin Kl-rich vegetable oil. Lipids 31:709-713. 
Booth. S. L.. L. J. Sokoll. O'brien. M. E.. B. Dawson-Hughes and J. A. Sadowski, 1995. 
Assessment of dietary phylloquinone intake and vitamin K status in postmanopausal 
women. E. J. Clin. Nutrition 49: 832-841. 
55 
Branson. H. E.. J. Katz. R. Marble, J. H. Griffin, 1983. Inherited protein C deficiency and 
courmarin-responsive chronic relapsing purpura flilminans in a newborn infant. 
Lancet 2: 1165-1168. 
Carlisle. T. L.. D. V. Shah. R. Schlegel and J. W. Suttie. 1975. Plasma abnormal protlirombin 
and microsomal prothrombin precursor in various species. Proc. Soc. Exp. Boil. 
Med. 148: 140-144. 
Chapman. H. Jr. Cheryl L. Allen, and O. Lee Stone, 1985. Human alveolar macrophages 
synthesize factor VII in vitro: Possible role in intestinal and lung disease. J. Clin. 
Invest. 75: 2030-2037. 
Conly. J. M.. 1992. The production of menaquinones (vitamin K2) by intestinal bacteria and 
their role in maintaining coagulation homeostasis. Prog. Food. Nutr. Sci. 16:307-343 
Conly, J. M.. and K. Stein. 1992. Quantitative and qualitative measurements of K vitamins in 
human intestinzil contents. The American Journal of Gastroenterology Vol. 87, No. 
3:311-316 
Cottrell. S.. C. M. Andrew. D. C. Layton and C. J. Powell. 1994. The dose-dependent effect 
of BHT (butylated hydroxytoluence) on vitamin K-dependent blood coagulation in 
rats. Fd. Chem. Toxic. 32: 589-594. 
Cracium. A. M.. M. C. L. Monique. Cees Vermeer. Groenen-Van Dooren, 1997. Nutritional 
vitamin K-intake and urinary y-carboxyglutamate excretion in the rats. Biochemica 
et Biophysica Acta: 1334: 44-50. 
Dahlbach. B. A. Lundwall. J. Stenflo. 1986. Localization of thrombin cleavage sites in the 
amino-terminal region of bovine protein S. J. Biol. Chem. 261: 5111-5115. 
56 
Dialameh. G. H.. W. V. Taggart. J. T. Matschiner and R. E. Olson, 1971. Isolation and 
characterization of menaquinone-4 as a product of menadione metabolism in chicks 
and rats. Intern. J. Vit. Nutr. Res. 41:391-400. 
Discipio. R. G.. M. A. Hermodson. S. G. Yates, E. W. Davie. 1977. A comparison of himian 
prothrombin, factor IX (Christmas factor), factor X (Stuart factor), and protein S. 
Biochemistry 16: 698-706. 
Dua, P. N.. E. J. Day. 1966. Vitamin K activity of menadione dimethylpyrimidinol bisulfite 
in chicks. Poultry Science 45: 94-96. 
Ducy. P.. C. Desbios. B. Boyce, G. Pinero, B. Story, C. Dunstan, E. Smith, J. Bonadio, S. 
Goldstein. C. Gundberg, A. Bradley, and G. Karsenty. 1996. Increased bone 
formation in osteocalcin-deficient mice. Nature 382: 448-452. 
Duello. T. J. and J. T. Matschiner. 1971. Characterization of vitamin K from pig liver and 
dog liver. Arch. Biochem. Biophys. 144:330-338 
Emster. L.. M. Ljunggren. L. Danielson, 1960. Purification and some properties of highly 
dicumarol-sensitive liver diaphorase. Biochem. Biophys. Res. Commun. 2:88-92 
Emster. L., L. Danielson. M. Ljunggren. 1962. DT diaphorase. I. Purification from the 
soluble fraction of rat-liver cytoplasma, and properties. Biochim. Biophys. Ata 
58:171-188 
Fasco. M. J.. L. M. Principe. 1982. Vitamin ICl hydroquinone formation catalyzed by a 
microsomal reductase system.. Biochem. Biophys. Res. Commun. 97:1487-1492. 
Ferland. G.. J. A. Sadovvski. M. E. O'Brien, 1993. Dietary induced subclinical vitamin K 
deficiency in normal human subjects. J. Clin. Invest. 91: 1761-1768. 
57 
Ferland. G. and J. A. Sadowski. 1992. Vitamin K1 (Phylloquinone) content of green 
vegetables: Effect of plant maturation and geographical growth location. J. Agri. 
Food Chem 40:1874-1877. 
Fieser. L. F.. M. Tishler. W. L. Sampson, 1941. Vitamin K. activity and structure. J. Biol. 
Chem. 137:659-692. 
Fisher. L. M.. G. J. Miller and L. B. Jaques. 1956. The effect of oral and intravenous 
administration of vitamin K on the prothrombin and proconvertin of 
cholecytnephrostomized dogs. Cand. J. Biochem. Physiol. 34:1039. 
Fraser. J. D. and P. A. Orice. 1988. Lung, hear, and kidney express high levels of mRNA for 
the vitamin K-dependent matrix Gla protein: Implication for the possible fimctions 
of matri.x Gla protein and for the possible distribution of the gamma carboxylase. J. 
Biol. Chem. 263: 11033-11036. 
Frick. P. G.. G. Riedler and H. Brogli. 1967. Dose-response and minimal daily requirement 
for vitamin K in man. J. Appl. Physiol. 23:387-389 
Frost. D. v.. H. C. Spruth. 1955: Control of hemorrohagic condition in chicks with mendione 
sodium bisulfite. Poultry Science 34: 56-63. 
Frost. D. v.. H. S. Perdue and H. C. Spruth, 1956. Vitamin K activity of menadione sodium 
bislufite in chickens. J. Nutrition 59: 181-196. 
Griminger. P. and O. Donis. 1960. Potency of vitamin Kl and two analogues in 
counteracting the effect f dicumarol and sulfaquinoxaline in the chick. J. Nitrition 
70:361-368. 
Griminger. P. 1957. On the vitamin K requirement of turkey poults. Poultry Science 36: 
1227-1235. 
58 
Griminger. P. 1965. Relative vitamin K potency of two water-soluble menadioen analogues. 
Poultry Science 44: 210-212. 
Groenen-Van Dooren. M. C. L., J. E. Ronden, B. A. M. Soute, and C. Vermeer, 1995. 
Bioavailability of phylloquinone and menaquinones after oral and colorectal 
administration in vitamin-K deficient rats. Biochemical and Pharmacology 50 
(6):797-801. 
Gustafsson. B. E.. F. S. Dafs. E. G. McDaniel. J. C. Smith, and R. J. Fizgerald, 1962. Effects 
of vitamin K-active compounds and intestinal microorganisms in vitamin K-
deficient germ-free rats. J. Nutrition 78:461-468. 
Haroon. Y. P. V. Hauschka. 1983. Application of high-performance liquid chromatography 
to the assay phylloquinone (vitamin K.1) in rat liver. J. Lipid Res. 24: 481-484. 
Hauschka. P. V. and M. L. Rei. 1978. Vitamin K dependence of a calcium-binding protein 
containing y-carboxyglutamic acid in chicken bone. J. Biol. Chem. 253: 9063-9068. 
Hauschka. P. V. and M. L. Reid. 1978. Timed appearance of a calcium-binding protein 
containing gamma-ion carboxyglutamic acid in developing chick bone. Dev. 
Biol.65: 426-434. 
Hauschka. P. V. and M. L. Reid. 1978. Vitamin K dependence of a calciimi-binding protein 
containing y-carboxyglutamic acid in chicken bone. J. Biol. Chem. 253: 9063-9068. 
Hauschke. P. V.. J. B. Lian. D. E. C. Cole. C. M. Gundberg^ 1989. Osteocalcin and matrix 
Gla protein: Vitamin K dependent proteins in bone. Phys. Rev. 69: 990-1047. 
Hirauchi. K.. T. Sakano. S. Notsumato. T. Nagaoka, A. Morimoto, K. Fujimoto, S. Masuda 
and Y. Suzuki 1989. Measurement of K vitamins in animal tissues by high-
59 
performance liquid chromatography with fluorimetric detection. J. Chromatigraphy 
497:131-137. 
Hollander, D. and Elena Rim, 1976. Vitamin K2 absorption by rat everted small intestinal 
sacs. Am. J. Physiol. 230 (2): 251-255. 
Hollander, D.. Elena Rim, and P. E. Ruble, Jr, 1997. Vitamin K2 colonic and ileal in vitro 
absorption: bile, fatty acids, and pH effects on transport. Am. J. Physio. 233:E 124-
129 
Ichihashi, Teruhisa. Yusushi Takagishi, Kiyohisa Uchida, and Hideo Yamada, 1992. Colonic 
absorption of menaquinone-4 and menaquinoe-9 in rats. J. Nutrition 122:506-512. 
Jie, K. S. G.. M. L. Bots, C. Vermeer. J. C. M. Witteman, D. E. Grobbe, 1995. Vitamin K 
intake and osteocalcin levels in women with and without atherosclerosis: a 
population-based study. Atherosclerosis 116: 117-123. 
fCindberg, C. G. and J. W. Suttie, 1989. Effect of various intakes of phylloquinone on signs 
of vitamin K deficiency and serum and liver phylloquinone concentration in the rat. 
J. Nutr. 119: 175-180. 
fCnap. M. H. J.. K. Hamulyak. C. Vermeen 1989. The effect of vitamin K. supplementation 
on circulating osteocalcin (bone Gla-protein) and urinary calcium excretion. Ann. 
Int. Med. 111:1001-1005. 
Knap. M. H. J.. Kon-Siong G. Jie. K. Hamulyak, and C. Vermeer. 1993. Vitamin K-induced 
changes in markers for osteoblast activity and urinary calcium loss. Calcif. Tissue 
Int. 53: 81-85. 
Knauer, T. E.. C. M. Siegfried, and J. T. Matschiner, 1976. Vitamin K requirement and the 
concentration of vitamin K in rat liver. J. Nutr. 106: 1747-1756. 
60 
Knauer. T. E.. C. Siegfried. A. E. Willingham and J. T. Matschiner, 1975. Metabolism and 
biological activity of cis- and trans-phylloquinone in the rat. J. Nutrition 105: 1519-
1524. 
FCohlmeier. M.. A. Salomon. J. Saupe and M. J. Shearer. 1996. Transport of vitamin K to 
bone in human. J. Nutr. 126: 1192S-11968. 
Korsan-Bengsten. K.. D. Elmfeldt. T. Helm. 1974. Prolonged plasma clotting time and 
decreased fobrinolysis in long-term treatment with alpha-tocopherol. Thromb. Diath. 
Naemorr. 31: 505-512. 
Larlar. R. A.. A. fCIeiss. J. H. Griffin. 1982. Mechanism of action of human activated protein 
C thrombin-dependent anticoagulant enzyme. Blood 59: 1067-1072. 
Lavelle. P. A., Q. P. Lloyd. C. A. Gay and R. M. Leach. Jr. 1994. Vitamin K deficiency does 
not impair skeletal metabolism of laying hens and their progeny. J. Nutr. 124: 371-
377. 
Leeuvven. J. P. T. M.. J. C. Birkenhager, G. C. M. Bemd and H. A. P. Pols. 1996. Evidence of 
coordinated regulation of osteoblast by I. 25-dihydroxyvitamin D3 and parathroid 
hormone. Biochim Biophys Acta. 1312: 55-62 
Lian. J. B.. M. Skinner. M. J. Glimcher, and P. Gallop, 1976. The presence of y-
carboxyglutamic acid in the proteins associated with ectopic calcification. Biochim 
Biophys Res Commun. 73: 349-355 
Lichtenthaler. H. tC.. 1993. The plant prenyllipids, including retenoids. chlorophylls and 
prenylquinones. Pages 421-464. In: plant lipids, Moore. T., Ed.. CRC press, Boca 
Raton. Fl. 
61 
Light, R. F.. R. P. Alsher. C. N. Frey, 1944. Vitamin A toxicity and hypoprothrombinemia. 
Science 100: 225-230. 
Luo. Guangbin. P. Ducy. M. D. McKee, G. J. Pinero, E. Loyer, R. R. Behringer, and G. 
Karsenty. 1997. Spontaneous calcification of arteries and cartilage in mice lacking 
matri.x Gla protein. Nature 386: 78-81. 
Luo, Guangbin. R. D'Souza, D. Hogue. and G. Karsenty. 1995. The matrix Gla protein gene 
is a marker of the chondrogenesis cell lineage during mouse development. J. Bone 
Mineral Res. 10: 325-334. 
March. B. E.. E. Wong. L. Seier, J. Sim. J. Biely, 1973. Hypervitamininosis E in the chick. J. 
Nutrition 103: 371-377. 
Mathers, J. C.. 1990. Dietary modification of potential vitamin K. supply from enteric 
bacterial menaquinone in rats. British J. Nutrition 63: 639-652. 
Matschiner. J. T. and R. G. Bell. 1972. Metabolism and vitamin K activity of cis 
phylloquinone in rats. J. Nutrition 102: 625-630. 
Matschiner. J. T. and W. V. Taggart. 1968. Bioassay of vitamin K by intracardial injection in 
deficient adult male rats. J. Nutrition 94: 57-59. 
Matschiner. J. T.. E. A. Doisy. Jr.. 1962. Role of vitamin A in induction of vitamin K 
deficiency in the rat. Proc. Exp. Boil. Med. 109: 139. 
Matschiner. J. T. and E. A. Diosy, Jr.. 1966. Bioassay of vitamin K in chickens. J Nutrition 
90: 97-100. 
Matschiner. J. T. and J. M. Amelotti, 1968. Characterization of vitamin K from bovine liver. 
J. Lipd Res. 9:176-179 
62 
Matschiner. J. T.. J. M. Amelotti. E. A. Doisy, Jr.. 1967. Mechanism of the effect of retinoic 
acid and squalene on vitamin K deficiency in the rat. J. Nutrition 91: 303-306. 
Miura. M.. H. Hiraike. M. fCimuraand Y. Itokawa, 1990. Conversion of vitamin K1 into 
menaquinone-4 in rat brain and plasma. Vitamins 64:459-462.' 
National Research Council. 1994. Nutrient requirement of poultry. National Academy Press, 
Washington- D. C. 
National Academy of Science. 1978. Nutrient requirement of laboratory animals. 3rd ed.. 
National Academy of Science. Washington. D. C. 
Nelson. T. S. and L. C. Norris. 1958. Further studies on the chick's requirement for vitamin 
K. PouItr\' Science 37: 1229. 
Nelson. T. S. and L. C. Norris. 1960. Studies on the vitamin K. requirement of the chick: 1, 
Requirement of the chick for vitamin Kl, menadione and menadione sodium 
bisulfite. J. Nutrition 72: 137-144. 
Oduho. G. W.. T. K. Chung and D. H. Baker. 1993. Menadione nicotinamide bisulfite is a 
bioactiv^e source of vitamin K and niacin activity for chicks. J. Nutrition 123: 737-
43. 
Olson. R. E.. 1984. The function and metabolism of vitamin K.. Ann. Rev. Nutr. 4:281-337 
Olson. R. E.. G. Philipps. N. T. Wang, 1968. The regulatory action of vitamin K. Adv. 
Enz>'m. Regul. 6: 213-225. 
Olson. R. E.. P. J. Jones. 1979. The inhibition of vitamin K action by d-a-tocopherol and its 
derivatives. Fed. Proc. 38: 2542. 
63 
Perdue. H. S.. H. C. Spruth and D. V. Frost. 1957. Comparison of vitamin K activities of 
vitamin K.1 and Klotogen (menadione sodium bisulfite complex). Poultry Science 
36: 633-635. 
Pineo. G. F.. A. S. Gailus. and J. Hirsh. 1973. Unexpected vitamin K deficiency in 
hospitalized patients. Can. Med. Assoc. J. 109:880-882. 
Price. P. A.. 1989. Gla-containing proteins of bone. Connect Tissue Res. 21: 51-60. 
Price. P. A.. M. K. Williamson, and J.W. Lothringer. 1981. Origin of the vitamin K-
dependent bone protein found in plasma and its clearance by kidney and bone. J. 
Biol. Chem 256:12760-12766 
Price. P. A.. Y. Kaneda. 1987. Vitamin K counteracts the effect of Warfarinin liver but not in 
bone. Thromb. Res. 46: 121-131. 
Price. P. v.. A. S. Otsuka. J. W. Poser. J. Kristaponis. N. Raman. 1976. Characterization of a 
gamma carboxyglutamic acid-containing protein from bone. Natl. Acad. Sci. USA 
73: 1447-1451. 
Prowse, C. V.. P. Mattock. M. P. Esnouf, A. M. Russel. 1976. A variant of prothrombin 
induced in cattle by prolonged administration of warfarin. Biochim Biophys Acta 
434: 265-279. 
Quick. A. J. and M. Stefanini. 1948. Experimentally induced changes in the prothrombin 
level of the blood. IV. The relation of vitamin K1 deficiency to the intensity of 
dicumarol action and to the effect of excess vitamin A intake. J. Biol. Chem. 
175:945. 
Quick. A. J.. 1935. The prothrombin in hemophilia and in obstructive jaundice. J. Biol. Chem 
109: XXIIl. 
64 
Quick. A. J. 1959. The coagulation of the blood and its role in hemostasis. Pages 38 — 42. in : 
Hemorrhagic disease. Lea & Febiger, Philadephia 
Ramotar. K.. J. M. Conly. H. Chubb, and T. J. Louie, 1984. Production of menaquinones by 
intestinal anaerobes. The Journal of Infectious Disease Vol. 150 :213-218. 
Rao. G. H.. K. E. Mason. 1975. Antisterility and antivitamin K. activity in the vitamin E-
deficient female rats. J. Nutrition 105: 495-498. 
Sadovvski- J. A.. H. fC. Schnoes. J. W. Suttie. 1977. Vitamin K epoxidase: properties and 
relationship to prothrombin. Biochemistry 16:3856-3863 
Sadwoski. J. A.. S. J. Hood. G. E. Dallal and P. J. GarT\'. 1989. Phylloquinone in plasma 
from elderly and young adults: factors influencing its concentration. Am. J. Clin. 
Nutr. 50: 100-108. 
Sakamoto. Naomasa. fCimura Micko. Hiraike Hidrkazu and Itokawa Yoshinori, 1996. 
Changes of phylloquinone and menaquinone-4 concentration in rat liver after oral, 
intravenous and intraperitoneal administration. Intemat. J. Vit. Nutr. Res. 66:322-
328. 
Saupe. J.. M- J. Shearer, and M. Kohlmeier. 1993. Phylloquinone transport and its influence 
on y-carboxyglutamate residues of osteocalcin in patients on maintenance 
hemodialysis. Am. J. Clin. Nutr. 58: 204-208. 
Shah. D. v.. J. C. Svvanson. and J. W. Suttie. 1984. Abnormal prothrombin in the vitamin K-
deficient rat. Thrombosis Research 35: 451-458. 
Shearer. M. J.. A. Bach, and M. Kohlmeier, 1996. Chemistry, nutritional sources, tissue 
distribution and metabolism of vitamin K with special reference to bone health. J. 
Nutrition 126:118 IS-11868. 
65 
Shearer. M. J.. A. McBumey. and P. Barkhan, 1974. Studies on the absorption and 
metabolism of phylloquinone (vitamin K.1) in man. Vitamins and Honnones: 
Advanced in Research and Application 32:513-542. 
Shearer. M. J.. 1995. Vitamin K. The lancet 345: 229-234. 
Shearer. M. J.. P. T. McCarthy. O. E. Crampton and M. E. Mattock, 1988. The assessment of 
human vitamin K status from tissue measurement. Pages 437-453. In: Current 
advancces in vitamin K research. Ed. Suttie. J. W„ Elsevier. New York, NY. 
Shearer. M. J.. R. von Kries. J. Saupe. 1992. Comparative aspects of human vitamin K 
metabolism and nutrition. J. Nutr. Sci. Vitamin. 3 (Suppl. 13):413-416 
Shelton. D. C.. G. C. Andeson. T. B. Clark and C. E. Weakley. Jr., 1956. Studies on tlie 
vitamin K requirement of the chick. Poultry Science 35: 1171. 
Stein. G. S.. J. B. Lian. L. C. Gerstenfeld. V. Shaloub, M. Aronow, T. Owen, and E. 
Martkose, 1989. The onset and progression of osteoblast differentiation is functional 
related to cellular proliferation. Connect. Tissue Research 20:3-13. 
Stentlo. J. 1976. A new vitamin K-dependent protein: purification from bovine plasma and 
preliminar\' characterization. J. Biol. Chem. 251: 355-363. 
Suttie J. W.. 1973. Mechanism of action of vitamin K: demonstration of a liver precursor of 
prothrombin. Science 179: 192-194. 
Suttie. J. W.. 1970. The effect of cycloheximide administration on vitamin K-stimuIated 
prothrombin. .Arch. Biochem. Biophys. 141: 571-578. 
Suttie. J. W.. 1991. Vitamin K. Pages. 145-194.In: Handbook of vitamins. Ed. Machlin, L. J. 
2nd ed. Marcel Dekker. New York, NY. 
66 
Suttie. J. W., J. M. Hagemen, S. R. Lehnnan and D. H. Rich, 1976. Vitamin K-dependent 
carboxylase: development of a peptide substrate. J. Biol. Chem. 25: 5827-5830. 
Suttie. J. W.. L. L. Mummah-Schendel, B. J. Shah, B. J. Lyle, and J. L. Greger, 1988. 
Vitamin K deficient from dietary vitamin K restriction in human. Am. J. Clin. Nutr. 
47; 475-480. 
Suzuki. H.. T. Nakao. K. Hiraga, 1983. Vitamin K. content of liver and feces from vitamin K-
deficient and butylated hydroxytoluene (BHT)-treated male rats. Toxicol. Appl. 
Pharmacol. 67:152-155. 
Suzuki, Y.. and M. Okamoto. 1997. Production of hen's eggs rich in vitamin K. Nutrition 
Research 17: 1607-1615. 
Taggat. W. v., K. Matschiner. 1969. Metabolism of menaquinone-6,7-3H in the rat. 
Biochem. J. 8: 1141-1146. 
Takahashi, O.. K. Hiraga. 1981. Inhibition of phylloquinone epoxide-dependent 
carboxylation of microsomal proteins from rat liver by 2,6-di-tert-butyl-4-
methylene-2.5-cycIohexadienone. Food Cosmetol. Toxicol. 19: 701-706. 
Takede. E.. K. L. Miyamoto. M. Kubota, H. Minami, I. Yokota. I. Yokota, T. Saijo, E, Naito, 
M. Ito. Y. Kuroda. 1994. Vitamin D-dependent rickets type II: regulation of human 
osteocalcin gene in cells with defective vitamin D receptors by 1,25-
dihydroxyvitamin D3. retinoic acid, and triiodothyronine. Biochim Biophys Acta 
1227: 195-199. 
Thijssen. H. H. W. and M. J. Drittij-Reijnders, 1994. Vitamin K distribution in rat tissues: 
dietar\' phylloquinoe is a source of tissue menaquinone-4. Br. J. Nutr. 72: 415-425. 
67 
Uchida, K.. Y. Nomura. H. Nakase, T. harauchi, T. Yoshizaki, H. Nakao, 1986. Effects of 
vitamin K-deficient diets and fasting on blood coagulation factors in convention and 
germ-free rats. Jpn. J. Pharmacol. 40: 115-122. 
Usui. Y.. H. Tanimura. N. Nishimura. N. BCobayashi, T. Okanoue and K. Ozawa, 1990. 
Vitamin K. concentration in the plasma and liver of surgical patients. Am. J. Clin. 
Nutr. 51: 846-852. 
Vermeer. C.. K. S. G. Jie. and M. H. J. Knappen, 1995. Role of vitamin K in bone 
metabolism. Aimu. Rev. Nutr. 15:1-22. 
Vermeer, C.. Birgit L. M. G. Gijsbers, A. M. Craciun, M. M. C. L. Groenen-Van Dooren and 
M. H. J. Knapen. 1996. Effects of vitamin K on bone mass and bone metabolism. J. 
Nutrition 126:L1I87S-I191S. 
Wallin. R.. O. Gebhardt. H. Prydz, 1978. NAD(P)H dehydrogenase and its role in the vitamin 
FC (2-methyI-3-phytyl-l,4-naphthoquinone)-dependent epoxidation in detergent-
solubilized fraction from rat liver. Biochem. J. 169:95-101. 
Wallin, R.. S. Hutson. 1982. Vitamin K-dependent carboxylation. Evidence that at least two 
microsomal dehydrogenase reduce vitamin K1 to support carboxylation. J. Biol. 
Chem. 257:1583-1586. 
Warner. E. D.. K. M. Brinkhous, and H. P. Smith, 1936. A quantitative study of blood 
clotting: Prothrombin fluctuation under experimental conditions. Am. J. Physiol. 114 
:667-675. 
Weber, von F. and O. Wiss, 1959. Die reakitivierung der bemsteinsaure-cytochrom-
reduktase durth die vitamine K1 und BC2 dem isoprenologen. Helvetica Chimica 
Acta 19:217-225. 
68 
Whitlon. D. S.. J. A. Sadowski. J. W. Suttie, 1978. Mechanism of coumarin action; 
Significance of vitamin K. epoxide reductase inhibition. Biochemistry 17:1371-1379. 
Widdershoven. J.. P. Van Munster. R. de Abreu, H. Bosman, T. van Lith, 1987. Four 
methods compared for measuring des-carboxy-prothrombin (PIVKA-II). Clin. 
Chem. 33: 2074-2078. 
Will. B. H.. and J. W. Suttie. 1992. Comparative metabolism of phylloquinone and 
menaquinone-9 in rat liver. J. Nutr. 122: 953-958. 
Will. B. H.. Usui Yuji. J. W. Suttie, 1992. Comparative metabolism and requirement of 
vitamin K in chicks and rats. J. Nutrition 122: 2354-2360. 
Willingham. A. K.. J. T. Matschiner. 1974. Changes in phylloquinone epoxidase activity 
related to prothrombin synthesis and microsommal clotting activity in the rats. 
Biochem. J. 140:435-441. 
Wiss. O. and H. Gloor. 1966. Absorption, distribution, storage, and metabolites of vitamin K 
and related quinone. Vitamins and Hormones 24:575-586. 
Wiss. O.. F. Weber. R. Ruegg und O. Isler. 1957. Uber die biologische aktivitat der vitamine 
KI and K2 und ihrer isoprenologen. Hoppe-Seyler's Zeitschrift Fur Physiologische 
Chemie 314: 245-249. 
Zimmerman. A.. J. T. Matschiner. 1974. Biochemical basis of hereditary resistance to 
Warfarinin the rat. Biochem. Pharmacol. 23:1033-1040. 
69 
EFFECT OF DIETARY VITAMIN K1 (K1) ON SELECTED PLASMA 
CHARACTERISTICS AND BONE ASH IN YOUNG TURKEY POULTS 
FED ADEQUATE OR DEFICIENT VITAMIN D3 DIETS 
A paper to be submitted to Poultry Science 
Shihou Jin and Jerry L. Sell 
Department of Animal Science. Iowa State University. Ames, lA 
ABSTRACT 
Three experiments (Exp.) were conducted to determine the effect of dietary Kl on 
selected plasma characteristics and bone ash in poults. In Exp. 1. diets were supplemented 
with 0, 0.5. I.O or 2.0 mg of Kl/kg. All diets contained 1.650 lU of vitamin D3 (D3)/kg. 
Dietary fCI had no effect on tibia ash at 7 d or incidence or severity of the rickets-like 
condition. Tibia ash of poults fed 2.0 mg of Kl/kg, however, was greater at 14 d of age than 
tibia ash of poults fed the basal diet. Dietary inclusion of 0.5 mg of Kl/kg was as effective as 
lor 2 mg of Kl/kg in reducing plasma prothrombin time. In Exp. 2. a 2^4 factorial 
arrangement was used consisting of 1650 or 550 lU of D3/kg and 0.1, 0.45, 1.0 and 2.0 mg of 
Kl/kg. Dietar\' D3 and Kl had no effect on bone ash. Dietary inclusion of O.l mg of Kl/kg 
seemed to be enough to minimize plasma prothrombin time. In Exp. 3. dietary treatments 
consisted of a Control (1.650 lU of D3 and 2.0 mg of Kl/kg) and Kl concentrations of 0, 
0.37. 2.28. or 5.33 mg/kg in diets containing 275 lU of D3/kg. Poults fed the low D3 diet 
without Kl consumed less feed and gained less weight, and had increased plasma alkaline 
phosphatase activity', decreased inorganic phosphorus level and decreased tibia ash (P <0.05) 
compared with those of poults fed the Control diet. Feed intake and body weight gain were 
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improved- plasma alkaline phosphatase activity tended to decrease, and plasma inorganic 
phosphorus increased when poults were fed the low D3 diet supplemented with 0.37 or 2.88 
mg of Kl/kg compared with poults fed the low D3 diet without K1 supplementation. Tibia 
ash of poults fed the low D3 diet was not affected by K1 supplementation. 
Keywords: vitamin D3. vitamin Kl, alkaline phosphatase activity, phosphorus, bone ash. 
INTRODUCTION 
Since its discovery in the late 1940s up to the early 1970s, vitamin K was thought to 
be needed only for the synthesis of four plasma clotting proteins in the liver, namely factors 
II (prothrombin). VII. IX and X. Research during the past two decades, however, has 
identified a substantial list of y-carboxyglutamic acid (Gla) containing proteins in various of 
tissues other than the liver. Soft tissues that actively synthesize Gla proteins include the 
kidneys (Booth. 1997). and uterine smooth muscle (Luo el ai, 1995). Some cells in the 
skeleton tissues, such as osteoblasts in bone (Hauschka and Reid, 1978) and the chondrocytic 
lineage cells in cartilage, also actively synthesize Gla proteins, such as osteocalcin and Gla 
matrix protein (Luo el ai. 1995). The process of post-translational carboxylation of glutamyl 
residues to y-carboxyglutamyl residues in these Gla proteins requires the presence of enough 
vitamin K.. because that this process is mediated by vitamin K-dependent carboxylases. The 
Gla residues in the vitamin K.-dependent proteins are essential for their fiill biological 
activities (Will et ai. 1992). Hence, vitamin K, through its effect on carboxylation, has an 
influence on the normal physiological functions of these Gla proteins. 
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There is evidence indicating an interaction between the biological functions of 
vitamin D and vitamin K. Leeuwen et al. (1996) reported that the expression of osteocalcin 
genes was regulated by vitamin D. One-25-(OH)2 D3 stimulated osteocalcin production in 
vitro in osteoblastic cell lines. Takede et al. (1994) postulated that the vitamin D receptor, 
which is a nuclear transcription factor, binds to the vitamin D response elements of the 
osteocalcin genes and regulates their expressions. The post-translational carboxylation 
process of osteocalcin has been shown to affect osteocalicin synthesis and intercellular 
processing (Nishimoto and Price, 1985). These observations indicate that there might be an 
interrelationship between vitamin D and vitamin K in the synthesis and processing of nascent 
osteocalcin. Sergee and Norman (1992) reported that 1.25-(OH)2 D3 receptor (VDR) 
underwent y-carboxylation in the presence of Kl in vitro, and 15 to 25 % of Glu residues in 
the VDR were carboxylated in vivo. It was suggested that the carboxylation of VDR might 
regulate its binding to DNA (Sergee and Norman, 1992). Sergeev and Spirichev (1989) 
reported that feeding rats a diet without adequate menadione sodium bisulfite 
supplementation resulted in an increase in bound VDR in the crude chromatin fraction of 
intestinal mucosa. The I. 25 -(OH)2 vitamin D3 binding capacity in the cytosol of intestinal 
mucosa was also increased in these vitamin K deficient rats (Sergeev and Spirichev, 1989). 
Vitamin K has been reported to affect some plasma parameters related to bone. 
Kjiapen et al. (1989) reported that the hydroxyapatite binding capacity of the circulating 
immunoreactive osteocalcin (irOC) was abnormally low in a selected group of 
postmenopausal women compared with premenopausal women. Administration of Kl (1 
mg/day) increased both the concentration and the hydroxyapatite binding capacity of 
circulating irOC. In a subsequent study, Knapen et al. (1993) showed that the increase of the 
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circulating irOC by the supplementation of K1 in elderly women was due to the increased 
serum irOC with a high affinity for hydroxyapatite, whereas the irOC with a low afiSnity for 
hydroxyapatite remained unaffected- BCnapen et al. (1993) reported that K1 supplementation 
in elderly women also resulted in increase of plasma bone specific alkaline phosphatase 
activity and a parallel increase in total plasma alkaline phosphatase. Akedo et al. (1992) 
reported that inclusion of MK-4 in culture medium suppressed proliferation of osteoblasts 
and increased alkaline phosphatase activity in vitro. In poultrv', Fleming et al. (1998) reported 
that supplementation of high level of menadione nicotinamide bisulfite in diets significantly 
reduced the loss of cancellous bone in the proximal tarsometatarsus in laying hens between 
15 to 25 weeks of age compared with hens fed a diet containing low level of menadione 
nicotinamide bisulfite. However. Lavelle et al. (1994) reported that menadione sodium 
bisulfite supplementation had no effect on gross and histological morphology of bone, 
cartilaginous tissues, and bone ash in young growing chicks, although chicks fed a diet 
without menadione sodium bisulfite supplementation exhibited increased plasma 
prothrombin times and reduced Gla contents in bone. 
Information in the literature on the effect of vitamin K on bone or related parameters 
in young growing animals is scarce and inconclusive. All reported research was conducted 
with an adequate supply of vitamin D. With the indication of a interaction between vitamins 
D and K. it will be informative to study the effect of vitamin K on bone or related parameters 
under conditions of adequate and deficient dietary vitamin D. Therefore, this research was 
conducted to determine the influence of dietary K1 on bone mineralization and related 
plasma parameters in young turkeys fed diets that were adequate or deficient in D3. 
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Concurrently, the dietary concentration of K1 needed to minimize plasma prothrombin time 
was evaluated. 
MATERIALS AND METHODS 
Diets 
In Experiment I. four dietary treatments were used. These consisted of a basal diet 
(Table I) supplemented with 0.0.5.1.0 or 2.0 mg of Kl/kg. The diets were fed in pelleted 
form from Days i to 7. and then, switched to mash form from 8 to 14 d of age. Each 
treatment was fed to four replicate pens with seven poults per pen from 1 to 14 d of age. 
Eleven poults in an extra pen were fed the basal diet in mash form for observation from 1 to 
14 d of age. In E.xperiment 2. a 2X4 factorial arrangement was used, consisting of two 
concentrations of D3 (1650 or 550 lU/kg) and four concentrations of K1 (0.1,0.45, 1.0 or 2.0 
mg /kg by analysis) supplemented to the basal diet shown in Table 1. except the vitamin 
premix contained no D3. Each treatment was fed to four replicate pens with eight poults per 
pen from Days I to 14. The diets were fed in mash form. In Experiment 3, dietary treatments 
consisted of a Control (1.650 lU of D3/kg and 2.0 mg of Kl/kg) and diets containing K1 
concentrations of 0. 0.37. 2.28 or 5.33 (by analysis) and 275 lU of D3/kg. The same basal 
diet shown in Table I was used to obtain the latter four dietary treatments, except the D3 
concentration was decreased to 275 lU/kg. Each treatment was fed to four replicate pens with 
eight poults per pen from 1 to 19 d, and the diets were fed in mash form. 
Animals 
One-day-old Nicholas poults were obtained from a commercial hatchery, and were 
randomly assigned to each experimental pen. The poults were kept in heated. 
74 
thermostatically controlled batteries with raised wire floors. Plastic sleeves, designed to filter 
out ultraviolet light, were put on all light sources in the room and in the batteries in 
E.xperiments 2 and 3. Water and feed were provided for ad libitum consumption. Water 
troughs were cleaned daily to reduce the possibility of production of vitamin K by 
fermentation. Fecal materials in feeders were removed daily, and excreta were cleaned 
frequently to minimize coprophagy. In Experiments I and 2. feed consumption and body 
weight were recorded weekly. Two blood samples were obtained fi-om each of two poults 
from each pen on 7 and 14 d. Citrate was used as anticoagulant for the blood samples fi-om 
which plasmas were used to determine prothrombin time. Heparin was used in blood samples 
from which plasmas were used for determination of Kl. MK-4and 25-OH-D3. After 
obtaining blood samples the poults were euthanitized by inhalation of Halothene*' . In 
Experiment 1. the right and left tibias were collected. The right tibia was used for histological 
evaluation and the left tibia was used to determine bone ash. In Experiment 2, only the left 
tibia was collected for bone ash determination. Body weight and feed consiunption data were 
recorded on Days 6. 13 and 19 in Experiment 3. Blood samples also were obtained on these 
same days from two poults per pen as described for Experiment 1 and 2. When poults were 
19 d old. left tibias were collected from two poults per pen for the determination of bone ash. 
Plasmas obtained when citrate was used as the anticoagulant were used to determine 
prothrombin clotting time, whereas plasmas obtained from heparinized blood were used to 
determine alkaline phosphatase activity and calcium and inorganic phosphorus 
concentrations. Plasma calcium and inorganic phosphorus were determined only on plasmas 
obtained on Days 13 and 19. 
' Halocarbon Labotories. River Edge. NJ 07661. 
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Analytical Procedures 
Plasma K1 and MK-4 levels were determined by the colleagues of University of 
Wisconsin" using the high performance liquid chromatography (HPLC) method of Haroon et 
al. (1986). The procedure to analyze plasma K1 or MK-4 was briefly; plasma samples were 
extracted through a liquid-phase with a ratio of plasma, water, ethanol, hexane of 1:2:3:9. 
After centrifiigation. the organic layer at the top of the supematent was harvested and 
evaporated to dryness. The dried sample was resuspended in hexane. filtered through a silica 
Sep-Pak cartridge, and eluted with a 3% mixture of ether in hexane. K1 and MK-4 were 
analyzed on a HPLC with a Zorbax CI8 reverse phase chromatography column and a zinc 
reduction column and a fluorescent detector. The zinc reduction colunm reduced vitamin K 
compounds to their fluorescent hydroquinones. The mobile solvent used was 15% methylene 
chloride in methanol with 5mL/L reductive solvent additive. The rate of solvent flow was set 
to 1.0 mL/min. and pressure was 7757 cm mercury. Excitation was performed at 244 nm and 
emission was monitored at 418 nm. The internal standard used was di-hydroKl. 
Plasma 25-OH-D3 was determined using the radioimmunoassay of Hollis et al. 
(1993). The primary goat antibody against 25-OH-D3 and the antigoat second-antibody were 
obtained from Incstar Corp^. The radioiodinated D3 was prepared firom 23, 24, 25, 26, 27-
pentanor-C22-carboxylic acid of D3. The procedure was briefly; a solution of the C22-acid 
of D3 and 1.1 -carbonyldiimidazole in dimethylforamide was allowed to react at 4 C for 2 
hours. 1.3-diaminopropane was then added, and allowed to react at 4 C for 16 hours and at 25 
C for 3 hours. Tlie 3-aminopropyl derivative of D3-C22-amide produced was combined with 
" Dr. Suttie and his group. Department of Biochemistry, University of Wisconsin. 
' Incstar Corp. Stillwater. MN 55082. 
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Bolton -Hunter reagent in dioxane. The resulting side-chain-radioiodinated D3 analogue was 
isolated and purified by silica gel chromatography. The assay calibrators were prepared from 
serum, stripped free of 25-OH-D3 by activated charcoal, and crystalline 25-OH-D3 dissolved 
in absolute ethanol. 25-OH-D3 in plasma samples and in the calibrators was extracted with 
actonitrile. and then after centrifligation the supematants were harvested to analyze 25-OH-
D3. 
One-stage prothrombin time was determined manually using a commercial 
thromboplastin preparation. Simplastin*^ E-xcel"^ Plasma inorganic phosphorus, calcium and 
total alkaline phosphatase activity were determined using commercial kits of procedures No. 
670. No.587 and No. 104"*. respectively, obtained from Sigma Diagnostics 
The left tibias were cooked in boiling water, and cleaned of flesh. The cleaned tibias 
were dried, and then ashed in a muffle ftimace at 600 C for 12 hours to determine ash 
content. The right tibias were trimmed of flesh at the time of dissection, and the proximal 
ends were cut longitudinally at the middle. Care was tziken not to displace the growth plate. 
The slice of the proximal end was fixed in 10% neutral buffered formalin for 2 to 3 days. The 
bone was then demineralized through a graded series of ethanol soutions, and infiltrated with 
paraffin. The bone tissue was sectioned at 5 |am. mounted and stained with hematoxylin and 
eosin. The histological structure of the tibia was examined under a microscope. 
Statistical Methods 
Data were analyzed using the General Linear Model (SAS Institute, 1996). When 
appropriate, linear and/or quadratic responses of the dependent variable to independent 
^ Sigma Diagnostics, St Louis. MO 63178 
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variable were tested. Single degree of freedom contrasts were used to determine the 
differences among treatment means when appropriate. Significance was declared when 
probability was less than 5%, and a trend was announced when probability less than 10%. 
RESULTS 
Experiment 1 
Dietarv' K1 concentration did not affect body weight gain, feed intake or feed 
efficiency of poults through 7 or 14 d of age (Table 2). Weight gain from I to 7 d was 
exceptionally good, averaging 124 g/poult.. At 7 d. however, more than 50% of poults in all 
dietary treatment groups developed leg weakness. Affected poults were reluctant to move, 
often sitting on their hocks. Some of them used wings to move around or keep their balance. 
Gross examination of longitudinal slices of tibias taken at 7 d showed the prevalence of 
overdeveloped growth plates with a thickness about 2 mm. Histological examination of tibias 
confirmed a rickets-like condition in all instzmces of poults fed the pelleted diets. In contrast, 
poults fed the basal diet that had not been pelleted showed no signs of leg weakness. Because 
only part of each experimental diet had been pelleted, the poults were changed to the no-
pelleted. mash form of the respective experimental diets from 8 to 14 d. By Day 14, poults 
showed few signs of leg weakness, irrespective of dietar\' Kl concentration. 
Bone ash concentrations of the tibias were relatively low at 7 d, irrespective of dietary 
Kl concentration (Table 3). At 14 d. bone ash was determined on only the tibias from poults 
fed the diet containing 2.0 mg of Kl /kg and fi-om poults fed the basal diet. The poults fed the 
basal diet included these in the observation group which were fed the basal diet in mash form 
from Day I and these in the experimental group which were fed in pelleted form during Days 
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I to7. and mash form during Day 8 to 14. Tliese data showed that percentage bone ash in the 
experimental group increased substantially as compared with the 7 d data, and was 
comparable to that of poults fed the basal diet in mash form from Day 1. Percentage bone ash 
of poults fed 2.0 mg of KI/kg was greater (P<0.05) than that of poults fed the basal diet. 
Supplementation of Kl in diets had no effect on plasma 25-OH-D3 levels (Table 3). At 7 d of 
age. plasma 25-OH-D3-levels in poults of all dietary treatment were lower (6.8 vs. 12.9 
ng/'ml) than values observed with normal poults at same age (Sell and Horst. 1994, 
unpublished data) Although poults in the experimental groups recovered from the leg 
weakness by 14 d of age. their plasma 25-OH-D3 levels were still lower (P < 0.01) than those 
of poults fed mash diet from Day I (7.96 vs. 11.70 ng/mL). 
Plasma prothrombin time decreased curvilinearly with the increase of dietary Kl 
(Table 4). Comparisons by single degree freedom contrast showed that the prothrombin times 
of poults fed diets containing 0.5. l.O or 2.0 mg of Kl/kg did not differ from each other, but 
they were all less than that of poults fed the diet without K I. At 7 d of age, plasma Kl 
concentration increased curvilinearly as dietary Kl level increase, and reached a apparent 
plateau when the dietary level of Kl reached 1.0 mg/kg (Table 4 and Figure I). Plasma MK-
4 concentration also increased curvilinearly as dietary Kl level increased (Table 4 and Figure 
1). At 14 d of age. plasma Kl and MK-4 concentrations, however, increased linearly with the 
increase of dietary Kl (Table 4 and Figure 2). 
79 
Experiment 2 
Poults fed diets containing 550 lU of D3/kg gained less weight compared with poults 
fed diets containing 1650 lU of D3/kg (Table 5). This effect of D3 was most evident during 
the 8 to 14 d age period. However, dietary D3 had no effect on feed intake. The dietary K1 
effect on body weight gain was not consistent (Table 5). with some effect detected during the 
first 7 days but no effect detected during the second week. Dietary K1 had no effect on feed 
intake. A significant interaction between dietary D3 and fCl was detected with efficiency of 
feed utilization (Table 5). Dietary Kl did not affect efficiency of feed utilization in poults fed 
diets containing 1650 lU of D3/kg. However, the efficiency of feed utilization was poorer 
statistically or numerically in poults fed diets containing 550 lU of D3/kg when 
supplemented with high levels of Kl (0.45 or more mg/kg) compared with that of poults fed 
diet containing 550 lU of D3/kg with O.l mg of Kl/kg. 
Plasma prothrombin times of poults fed diets containing 1650 lU of D3/kg tended to 
be longer than that of poults fed diets containing 550 lU of D3/kg at 14 d of age but not at 7 d 
of age (Table 6). However, dietary D3 had no effect on bone ash and plasma Kl 
concentrations (Table 6). Dietary Kl concentration of O.l mg/kg was as effective as 0.45, 1.0 
or 2.0 mg/kg in reducing plasma prothrombin time. Plasma Kl increased linearly with the 
increase of dietary Kl level. There was an indication of an interaction between dietary D3 
and Kl on bone ash {P<0.10). Bone ash was not affected by the increase of dietary Kl when 
poults were fed diets containing 1650 lU of D3/kg, whereas an increase of dietary Kl tended 
to have a adverse effect on bone ash in poults were fed diets containing 550 lU of D3/kg. 
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Experiment 3 
Dietary treatment effects on poult performance were evident from Day 7 and onward, 
whereas this effect was not detected during the first 6 days (Table 7). Poults fed the diet 
supplemented with 275 lU of D3/kg and 0 mg of BCl/kg gained less weight (P<0.05), 
consumed less feed (P<0.05) compared with poults fed the Control diet. Body weight gain of 
poults fed the low D3 diet, when supplemented with K1 at the concentration of 0.37 or 2.88 
mg/kg. was improved fP < 0.05 or P<0.01) compared with that of poults fed the low D3 diet 
without supplementation of K.I. Supplementation of Kl at 0.37 or 2.88 mg/kg to the low D3 
diet also increased or tended to increase feed intake (P<0.06 or P<0.03) compared with that 
of poults fed the low D3 diet without supplementation of Kl. However, body weight gain 
and feed intake were not improved in poults fed the low D3 diet when supplemented with 
5.33 mg of Kl/kg compared with poults fed low D3 diet without Kl supplementation. The 
dietary treatment effect on efficiency of feed utilization was not consistent. For example, the 
overall efficiency of feed utilization from Days 1 to 19 was not influenced by dietary 
treamients. but during 7 to 13 d age period, poults fed the low D3 diet without Kl 
supplementation utilized feed less efficiently than poults fed the Control diet. 
Poults fed a diet containing 275 lU of D3/kg and 0 mg of Kl/kg had increased plasma 
alkaline phosphatase activity on Days 13 (P< 0.02) and 19 (P<0.05) but not on Day 6 
compared with poults fed the Control diet (Table 8). The increased plasma alkaline 
phosphatase activity of poults fed the low D3 diet was decreased or tended to decrease (with 
the exception that plasma alkaline phosphatase activity on Day 19 of poults fed a diet 
supplemented with 2.0 Kl/kg was decreased numerically) when the low D3 diet was 
supplemented with Kl compared with that of poults fed the low D3 diet without Kl 
81 
supplementation. The effect of dietary treatments on plasma calcium concentration was not 
consistent, with no effect detected on Day 13 but a trend toward decreased plasma calcium as 
dietary KI increased during observed at Day 19. Plasma inorganic phosphorus levels of 
poults fed a low D3 diet without supplementation of KI was lower compared with poults fed 
the Control diet (P < 0.05). Supplementation of the low D3 diets with 0.37 or 2.28 mg of KI 
/kg increased the plasma inorganic phosphorus sigm'ficantly on Day 13 (P<0.08 or P < 0.03, 
respevtively) and numerically on Day 19 compared with that of poults fed the low D3 diet 
without KI supplementation. However, supplementation with the high level of KI (5.33 
mg/kg) to the low D3 diet had no effect on plasma inorganic phosphorus level compared with 
that of poults fed the low D3 diet without KI supplementation. Bone ash of poults fed the 
low D3 diet without KI supplementation was lower than that of poults fed the Control diet. 
The effect of supplemental KI in the low D3 diet on bone ash was not consistent. No effect 
of supplemental KI to the low D3 diets on bone ash was detected when the supplemental 
level was 0.37 or 5.33 mg/kg. whereas an adverse effect was detected when KI was 
supplemented at the level of 2.28 mg/kg. 
DISCUSSION 
Although substantial research has been conducted to study leg weakness of turkeys, 
the causes of leg weakness are not well understood. In the literature, there were several case 
reports in which leg weakness of turkeys was termed as "field rickets." This kind of leg 
weakness often occurred at very young ages, and the known nutritional factors or infectious 
diseases were not the causes. Walser et al. (1980) reported two cases of field rickets in poults 
at 16 to 20 d of age. Tlie incidences of field rickets affected about 20% of the flocks, and 
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affected poults were reluctant to move, leaned forward and supported their weight with their 
wings. Bones of affected poults were soft, fragile and hypomineralized. The growth plates of 
tibias were thickened. In a subsequent study, Olson et al. (1981) observed that affected poults 
had decreased plasma phosphorus and increased alkaline phosphatase activity. Plasma 24, 
25-dihydroxy D3 levels in affected poults were lower than normal values. Analysis of the 
rations of affected poults, however, showed that adequate concentrations of dietary calcium, 
phosphorus and D3 were present. Further supplementation of calcium and/or phosphorus did 
not prevent occurrence of the problem. Riddell (1983) reported that most outbreaks of field 
rickets staned when poults were between 10 to 14 d of age. Skeletal lesions of affected poults 
were characteristics of a vitamin D3 or calcium deficiency. On the basis of chemical analysis, 
adequate calcium, phosphorus and D3 were present in diets. Biological tests implicated, 
however, that the feed was the causative factor of the field rickets. All these diets that caused 
leg weakness were fed in pelleted form. 
Tlie leg weakness, observed in the research reported here, had some similarities to 
field rickets. The problem occurred when poults were only about 7 d of age, and a high 
percentage of poults were affected. The poults were fed pelleted diets. The affected poults 
were reluctant to move, often sitting on their hocks. Gross and histological examination of 
tibias showed the prevalence of overdeveloped growth plates and vitamin D deficiency 
symptoms. Plasma 25-OH D3 levels were only about half of the values observed in normal 
poults of the same age (Sell and Horst. 1994, unpublished data). However, poults fed the 
basal diet in mash form did not show any signs of leg weakness. When the experimental diets 
were switched to mash form from Day 8, poults began to recover from the leg weakness. The 
cause of the leg weakness in this research was difficult to pin down, but it was unlikely that 
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the leg weakness in Experiment 1 was caused by D3 deficiency. The D3 stores firom the 
residual yolks and body tissues should not have been depleted at such an early age Jis Day 7. 
A low D3 diet such as 275 lU of D3/kg in Experiment 3 did not result in similar leg 
weakness. It was speculated that the pelleting process caused some chemical changes in the 
nutrients or other substances in the diets which, in turn . that resulted in the high incidence of 
leg weakness. 
Feeding diets containing 1.650 lU of D3/kg tended to increase plasma prothrombin 
time on Day 14 but not on Day 7. The absence of the effect of D3 on prothrombin time on 
Day 7 perhaps reflected the fact that poults obtained some D3 and vitamin K from the 
residual yolks during the first few days posthatch. The increased prothrombin time at Day 14 
observed with poultys fed 1.650 lU of D3/kg is consistent with the anticoagulant effect of D3 
reported by Koyama et al. (1998). These authors reported that inclusion of l,25-(OH)2 D3 in 
culture media had an anticoagulant effect in vitro through dowiu-egulating tissue factor 
expression and upregulating thrombomodulin expression. Tissue factor is one of the 
accessory factors to enhance the activity of the Stuart factor (factor X) by activating 
proconvertin (factor VII) in the extrinsic pathway of blood coagulation (Voetand Voet, 
1995). Thrombomodulin specifically binds to thrombin so as to convert it to a form with 
decreased ability to catalyze clot formation but with increased capability to activate protein 
C. which is a plasma protein with the ability to limit blood clotting (Voet and Voet, 1995). 
Plasma Kl and MK-4 concentrations generally increased as the dietary concentratioa 
of K1 increase. However. Plasma Kl and MK-4 concentrations increased curvilinearly at 
Day 7 (Figure 1) in Experiment I, whereas increased linearly at Day 14 in Experiment 
1 (Figure 2) and in Experiment 2 (Figure 3). This curvilinear increase of plasma Kl and MK-
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4 on Day 7 in Experiment I was probably because some of the poults might be off feed for a 
while as a consequence of the leg problem. It has been indicated that plasma K1 is cleared 
from the circulation very quickly. Shearer et al. (1972) reported that 2 and 8 hours after 
administration only about 10 and 1% of the initial radioactivity remained in the plasma, 
respectively after either oral or intravenous administration of radio-active labelled Kl. 
The adverse effects of vitamin K. antagonists, such as warfarin, on rapidly growing 
bones were well documented. Warfaringiven to young rats causes premature growth plate 
closure (Shearer. 1995). A parallel in humans to these effects is the fatal Warfarinsyndrome, 
characterized by the excess calcification of the epiphyses and irregular growth of the facial 
and long bones (Shearer. 1995). However. The effect of vitamin K antagonists on mature 
bone is inconclusive. Some researchers showed that long-term intake of a vitamin K 
antagonist reduced bone mineral content (Fiore et al., 1990: Fesch et al., 1993) whereas 
others did not ( Rosen et al.. 1993). Information on the effect of vitamin K on bone is limited. 
Lavelle et al. (1994) reported that bone histological structure and bone ash were not affected 
in chickens although these chickens were progeny of hens fed a vitamin K deficient diet and 
were raised on vitamin K. deficient diets themselves. However. Fleming et al. (1998) reported 
that dietar>' supplementation of 10 mg of menadione/kg from menadione nicotinamide 
bisulfite significantly reduced cancellous bone loss in the proximal tarsometatarsus of laying 
hens between 15 to 25 weeks of age. It was observed in the current research that 
supplementation of Kl had no effect on the histological structure of bone, or the incidence or 
severity of the leg weakness. However, supplementation of 2.0 mg of Kl/kg significantly 
increased bone ash in poults during a recovery from leg weakness compared with poults fed a 
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diet without Kl supplementation. An interpretation of this observation is difficult because the 
causes of the leg weakness remained undetermined. 
Compared with poults fed a diet containing adequate D3 and Kl, poults fed low D3 
diet without K1 had increased plasma alkaline phosphatase activity and decreased inorganic 
phosphorus levels. These symptoms are some of the signs of D3 deficiency. When poults 
were fed the low D3 diet supplemented with a low level of Kl (0.37 or 2.28 mg/kg), plasma 
alkaline phosphatase activity decreased or tended to decrease, and plasma inorganic 
phosphorus levels were increased statistically or numerically compared with that of poults 
fed the low D3 diet without supplementation of Kl. An increase in feed intake in response to 
supplementation of Kl to the low D3 diet probably accounted for some, but might not all, of 
the changes in plasma alkaline phosphatase and inorganic phosphorus. For example, 
supplementation of the low D3 diet with 0.37 mg of Kl/kg resulted in a increase of feed 
intake by 7.9% during the period of Days 7 to 13. whereas plasma alkaline phosphatase 
activity was decreased by 28% and plasma inorganic phosphorus level increased by 39.5% 
compared with poults fed the low D3 diet without Kl. The decrease of plasma alkaline 
phosphatase activity and the increase of inorganic phosphorus, resulted by supplementation 
of Kl at a level of 0.37 or 2.88 mg/kg in the low D3 diet, probably also related to the 
suggestion that status of vitamin K-dependent carboxylation of vitamin D3 receptor might 
regulate its binding to DNA (Sergee and Norman, 1992), and therefore, the biological 
functions of D3. Sergee and Norman (1992) reported that VDR underwent y-carboxylation in 
the presence of Kl in vitro, and 15 to 25 % of Glu residues in the VDR were carboxylated in 
vivo. 
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TABLE 1. Composition of the basal diet 
Ingredients Content 
(g/kg) 
Soybean meal (48%CP) 567.03 
Corn starch 267.70 
Sunflower meal 80.00 
Stripped com oil 39.02 
Dicalcium phosphate 23.83 
Lime stone 12.67 
Vitamin premix' 3.00 
Mineral premi.x" 3.00 
DL-Methionine 2.00 
NaCl 1.50 
BMD 0.25 
Calculated nutrient composition 
ME. kcal/kg 2850 
CP. % 28.5 
TSAA.% 1.05 
Lysine. % 1.69 
Calcium. % 1.20 
Available phosphorus. % 0.60 
K l .  m g / k g  l e s s  t h a n  0 . 0 2 ^  
' Provided per kg diet: vitamin A (retinyl acetate), 8190 lU; d[-^-tocopherol acetate, 30 lU; 
vitamin D3 (choiecalciferol). 1.650 lU. vitamin B12, 15.9 pantothenic acid, 13.2 mg; niacin, 
75 mg; choline. 5090 mg; folic acid. 2.4; biotin 0.27 mg; pyrodixine HCI 6.0 mg; thiamine 
mononitrate 2.4 
" Supplied per kg diet: Mn. 70 mg; Zn. 40 mg; Fe, 37; Cu, 6mg; Se, 0.15 mg; NaCI (I), 2.60 g. 
Bacitracin dimethylene salicylate. 
^ The detection limit of phylloquinone analysis. 
TABLE 2. Effcct of dictar)' K1 concentrations on body weight gain, feed intaiic and feed efficiency in young poults (Exp. 1) 
Supplemental Body Weight Weight Gain Feed Intake Feed Efficiency' 
K 1  7 d  1 4 d  l - 7 d  7 - l 4 d  l - 1 4 d  l - 7 d  7 - 1 4 d  l - i 4 d  l - 7 d  7 - 1 4 d  l - 1 4 d  
(nig/kg) (g/poult) — Feed : weight 
0 177 314. 120 137 257 138 192 330 1.16 1.46 1.29 
0.5 181 316 123 135 258 144 187 331 1.16 1.44 1.28 
1.0 183 320 127 136 263 149 193 3428 1.17 1.51 1.30 
2.0 184 323 126 141 267 147 193 340 1.17 1.41 1.28 
SEM 3.6 8.2 3.5 5.5 7.9 3.6 4.2 7.9 0.02 0.06 0.02 
Sources of variation Probabilities 
Linear 0.27 0.38 0.20 0.25 0.34 0.08 0.44 0.80 0.81 0.24 0.28 
Quadratic 0.33 0.92 0.31 0.33 0.91 0.16 0.36 0.62 0.94 0.26 0.87 
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TABLE 3. Effect of dietary Kl concentrations on bone asii and plasma 25-OH 
vitamin P3 levels in young poults (Exp» 1) 
Supplemental Bone ash 25-OH vitamin D3 
K I  7 d  I 4 d  7 d  1 4 d  
(mg/kg) (%) (ng/ml) 
0 30.4 34.3 6.56 6.65 
0.5 31.2 ND 4.84 8.84 
1.0 31.3 ND 7.06 7.59 
2.0 31.0 36.9 8.92 8.06 
0 (mash) ND 37.9 ND 11.70 
SEM 0.29 0.40 1.63 1.41 
Source of variation Probabilities 
Treatments 0.26 0.05 0.33 0.33 
^ ND stands for not determined 
" The data was analyzed without inclusion of data from poults fed the basal diet in mash form from Day I. 
93 
TABLE 4. Effect of dietary K1 concentrations on prothrombin time and plasma K1 
and menaquinone-4 concentrations in young poults (Exp. 1) 
Supplemental Prothrombin time Plasma K1 Plasma MK-4 
K l  7 d  I 4 d  7 d  I 4 d  7 d  I 4 d  
(mg/kg) (Seconds) (ng/mL) 
0 437 356 O.IO 0.05 0.32 0.61 
0.5 155 156 4.25 1.68 1.16 2.94 
1.0 147 116 4.86 3.36 4.12 5.41 
2.0 121 114 2.95 7.29 6.19 9.73 
SEM 36.4 34.7 1.54 2.23 1.69 2.29 
Sources of variation Probabilities 
Linear 0.08 0.006 0.295 0.002 0.001 0.0001 
Quadratic 0.053 0.001 0.0005 0.011 0.0003 0.0002 
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Figure I. Effect of dietary K.I concentrations on plasma phylloquinone and 
menaquinone-4 concentraticKis at 7 d. Experiment 1 
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Figure 2. Effect of dietary phylloquinone on plasma phylloquinone and 
menaquinone-4 concentrations at 14 d. Experiment 1. 
TABLE 5. Effcct of dictar}' concentrations of vitamin D3 (D3) and K1 on weight gain, feed Intake and feed 
efficiency in poults (Exp. 2) 
Supplemental Body weight Gain Feed Intake Feed efficiency' 
D 3  K 1  7 d  1 4 d  l - 7 d  8 - 1 4 d  l - H d  l - 7 d  8 - 1 4 d  l - 1 4 d  I - 7 d  8 - 1 4 d  1 - I 4 d  
(llJ)(mg/kg) — (g/poull) Feed : gain 
0.1 160 385 % 225 321 95 276 372 0.99 1.23 1.15 
0.45 160 385 96 225 321 95 273 368 0.99 1.21 1.14 
1650 
1.0 163 388 100 224 324 97 275 371 0.98 1.23 1.14 
2.0 162 386 98 224 322 96 274 369 0.98 1.22 1.14 
0.1 161 389 97 228 324 96 278 374 0.96 1.22 1.15 
0.45 150 366 86 215 302 95 282 377 1.10 1.31 1.25 
550 
1.0 160 376 96 216 312 96 271 367 1.00 1.26 1.17 
2.0 163 381 99 218 316 100 272 372 1.02 1.25 1.17 
SEM 1.6 5.1 2.4 3.5 5.5 1.8 4.9 6.4 0.01 0.01 0.01 
Sources of variation —. Probabilities 
D3 0.13 0.05 0.04 0.05 0.05 0.69 0.58 0.13 0.0001 0.0003 0.0001 
K1 0.02 0.21 0.02 0.25 0.24 0.52 0.63 0.92 0.0002 0.06 0.0007 
D 3 * K 1  0 . 1 6  0 . 2 3  0 . 1 8  0 . 2 6  0 . 2 4  0 . 6 1  0 . 6 3  0 . 4 8  0 . 0 0 2  0 . 0 0 2  0 . 0 0 0 1  
'Feed to gain ratio. 
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TABLE 6. Effect of dietary levels of vitamin D3 (D3) and Kl on prothrombin time, 
plasma Kl levels and bone ash (Exp. 2) 
Supplemental Prothrombin time Plasma Kl Bone ash 
D3 Kl Id 14d 14 d 14 d 
(Seconds) (ng/ml) (%) 
0.1 146 138 0.06 40.1 
1650 0.45 135 142 1.44 40.6 
l.O 132 115 3.79 41.1 
2.0 130 113 7.87 41.4 
0.1 149 105 0.18 41.4 
0.45 140 94 1.75 39.9 
550 1.0 124 91 2.81 40.4 
2.0 122 94 8.03 40.5 
SEM 13.5 11.5 0.98 0.46 
Source of variation Prohahilirie.s 
D3 0.99 0.07 0.92 0.96 
Kl 0.59 0.20 0.002 0.61 
D3 * Kl 0.99 0.57 0.96 0.10 
TABLE 7. Effcct of dictar}' supplementation of K1 on body weight gain, feed intake and feed efficiency in poult (Exp. 3) 
" ' ^ ^ " ' • III... • I—• I •• • T 
Supplemental Body weight Weight Gain Feed intake Feed efficiency 
K1 6d TTd mi 1-6 d 7-13 d 1-19 d l-6d 7-13dl-19d l-6d 7-13d l-19d 
(g/poult) — Feed : gain 
Control." 140 330 545 78 190 483 82 233 627 1.06 1.29 1.30 
0 136 289 469 75 153 408 76 204 540 1.02 1.34 1.32 
0.37^ 133 310 500 73 177 440 74 220 576 1.02 1.25 1.31 
2.28 138 307 513 77 169 453 78 213 582 1.02 1.26 1.29 
5.37 141 304 483 78 164 420 75 213 551 0.96 1.30 1.31 
SEM 2.8 5.8 10.7 3.8 4.2 10.5 2.2 3.9 12.6 0.03 0.03 0.02 
Source of variation - Probabilities 
Treatment 0.35 0.03 0.002 0.64 0.0002 0.001 0.16 0.002 0.002 0.37 0.050.57 
' Feed to gain ration 
' The diet contained 1650 lU vitamin D3 and 2.0 mg Kl per kilogram. 
^ Milligrams of KI per kilogram of diets that contained 275 lU of vitamin D3 
TABLE 8. Effcct of dictarj' supplemental K1 on plasma parameters related to bone metabolism and bone 
ash in poults fed on low vitamin 1)3 diets (Exp. 3) 
Trealmenis Alkaline phosphatase Ca P Bone ash 
Day 6 Day 13 Day 19 Day 13 Day 19 Day 13 Day 19 Day 19 
— (|.imol p-nilrophenol released/ml/15 min)— (mg/dL) — (%) 
Control 79.3 70.0 54.6 7.2 9.9 4.9 7.1 42.9 
0 75.3 103.9 91.5 8.6 9.2 3.9 5.0 39.1 
0.37 84.1 74.3 67.7 8.9 8.7 5.5 6.2 40.2 
2.28 78.6 74.9 81.4 8.9 8.7 6.2 6.2 38.4 
5.33 84.7 80.6 69.8 8.5 8.7 4.7 6.1 39.4 
SEM 5.68 6.56 8.36 l . l l  0.31 0.64 0.70 0.52 
Source of variation Probabilities — -
Treatment 0.77 0.018 0.063 0.77 0.07 0.06 0.08 0.002 
' The diet contained 1650 lU vitamin D3 and 2.0 mg K! per kg. 
^ Milligram of Kl in diets containing 275 lU vitamin D3 per kg 
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DIETARY VITAMIN K1 REQUIREMENT OF YOUNG TURKEY POULTS 
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ABSTRACT 
In a preliminary experiment (Exp.), the inclusion of vitamin KI (Kl) at a dietary level 
of 0.1 mg/kg was as effective as 1 or 2 mg /kg in reducing plasma prothrombin time (PT). To 
obtain an estimate of the dietary Kl requirement of poults, three additional Exp. were 
conducted. In Exp. I. a 2x3 factorial arrangement was used with two concentrations of 
neomycin (0 or 75mg/L) in the drinking water and three concentrations of Kl (0, 0.1 or 0.5 
mg/kg) in diets. Each treatment was fed to two pens with eight poults per pen, and individual 
poults were used as experimental units for the determination of PT and prothrombin 
concentration (PC) in plasma. PT and PC in plasma were not influenced by inclusion of 
neomycin in drinking water. However. PT was reduced to a nadir and PC in plasma increased 
to a plateau when diets contained O.lmg of Kl/kg. Dietary Kl concentrations tested in Exp. 2 
were 0. 0.08. 0.31 or 0.44 mg/kg and in Exp. 3 were 0, 0.1. 0.25, 0.5 or 2.0 mg/kg. A similar 
protocol as that of Exp. I was used in these two Exp. The results of Exp. 2 indicated that the 
dietary Kl requirement was 0.079mg, based on the influence of dietary Kl on PT. The Kl 
requirement was estimated, on the basis of PT and PC, to be 0.099 and 0.13 mg/kg, 
respectively, in Exp. 3. Results of this research show that the dietary Kl requirement of 
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young turkeys is in the range of 0.079 to 0.13 mg/kg, and ingestion of neomycin did not 
affect estimates of the requirement. 
Keywords: vitamin KI requirement, prothrombin time, prothrombin concentration, 
menaquinone-4. turkey. 
INTRODUCTION 
Vitamin K is a general term used for a series of compounds with a structure of 
polyisoprenoid-substituted naphthoquinone. It is traditionally classified into Kl 
(phylloquinone) and K2 (menaquiones), according to their origination from plants or 
bacteria, respectively. A group of synthetic menadione derivatives such as menadione 
sodium bisulfite, etc. also have biological activity of vitamin K. The K, vitamins are essential 
cofactors for microsomal vitamin K-dependent carboxylases, which catalyse a post-
translational conversion of glutamyl residues in the nascent precursors to y-carboxyglutamyl 
residues (Gla) in their respective mature proteins (Suttie. 1985). Gla proteins have been 
shown to be actively synthesized in various tissues such as liver, kidneys (Booth, 1997), bone 
(Hauschka and Reid. 1978) and cartilage (Luo el ai. 1995), The Gla residues in these Gla 
proteins are essential for their full zind wide variety of biological functions (Will et aL, 1992). 
The vitamin K requirement of animals, such as turkeys, is met by a combination 
supply from the diet and from microbial synthesis in the gastrointestinal tract. Intake of 
broad-spectrum antibiotics, such as neomycin, has been shown to reduce the production of 
menaquinones in the intestinal tract by microbial flora. Frick et al. (1967) reported that 
starvation combined with an intake of broad-spectrum antibiotic resulted in vitamin K 
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deficiency in humans whereas starvation alone did not. This observation was coniirmed by 
UdaII(1965). 
Existence of a dietary requirement of vitamin K of chicks has been recognized for a 
long time (Almquist. 1939), However, there is very little information on the vitamin K 
requirement of turkeys. On the basis of protiirombin times of young turkeys, Griminger 
(1957) reported that, when menadione sodium bisulfite or menadione was used as sources of 
vitamin K.. tlie requirements were I. I and 1.76 mg/kg diet respectively. It should be noted 
that plasma prothrombin time is a non-specific index of vitamin K status. Quick (1959) stated 
"when the test was developed, thromboplastin and prothrombin were accepted as the two 
basic agents needed for the generation of thrombin ... However, It has been documented 
that there are many factors other than thrommboplastin and prothrombin (Voet and Voet, 
1995) involved in the conversion of prothrombin to thrombin. Kindberg and Suttie (1989) 
stated that one-stage prothrombin time was a less sensitive index of vitamin K status than 
some other methods, such as plasma prothrombin level. 
The dieteiry vitamin K requirement of young turkeys listed by National Research 
Council (1994) is actually a menadione sodium bisulfite requirement based on the data of 
Griminger (1957) and no requirement for vitamin K1 is given. Griminger and Donis (1960) 
reported that the KI requirement of chicks fed a purified diet was 1 mg/kg of diet. Nelson 
and Norris (1958) estimated the K.I requirement for chicks varied from 0.4 to 0.6 mg/kg diet 
This latter observation was confirmed by Nelson and Norris (1960). Results of previous 
research in our laboratory, which involved use of different dietary concentrations of Kl, 
indicated that young turkeys might require less that 0.1 mg of Kl/kg. The objective of the 
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research reported here was to determine the K.1 requirement of young turkeys by using 
plasma prothrombin time and plasma prothrombin concentration as primary criteria. 
MATERIALS AND METHOD 
Diets and Treatments 
In Experiment I. a 2 X 3 factorial arrangement was used with two concentrations of 
neomycin (0 or 75 mg/L) in the drinking water and three concentrations of Kl (0, 0.1,0.5 
mg/kg) supplemented to the basal diet shown in Table I. Each treatment was fed to two pens 
with eight poults per pen from Days 1 to 7. Diets were fed in mash form. Dietary Kl 
concentrations tested in Experiment 2 were 0, 0.08, 0.31.0.44 or 1.8 mg/kg (by analysis) 
based on the diet shown in Table 1. Each treatment was fed to two pens with ten poults per 
pen from Days 1 to 7. In Experiment 3. dietary treatments consisted of 0, 0.1, 0.25, 0.5 or 2.0 
mg of Kl/kg supplemented to the basal diet shown in Table I. Each treatment was fed to two 
pens with eight poults per pen from Days 1 to 7. 
Animals 
One-day-old Nicholas male poults were obtained from a commercial hatchery, and 
were randomly assigned to each treatment pen. The poults were kept in heated, 
thermostatically controlled batteries with raised wire floors. Water and feed were provided 
for ad lihitiim consumption. Water troughs were cleaned daily to reduce the possibility of 
production of menaquiones by microbial fermentation. Excreta in feeders also were removed 
daily. Droppings under the battery pens were removed frequently to minimize coprcphagy. In 
Exp 1. body weight and feed consumption data were recorded when poults were 7 d of age, 
then, two blood samples were obtained from each poult of every pen. Citrate was used as 
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anticoagulant for the blood samples from which plasmas were used to determine prothrombin 
times. Heparin was used in blood samples from which plasmas were used for determination 
of plasma prothrombin concentrations. In Exp 2, body weight and feed consumption were 
recorded when poults were 7 d of age, then, one blood sample was obtained from each poults 
of every pen. A similar protocol as described in Exp 1 was used for plasma obtainment to 
determine prothrombin time. In E.xp 3. body weight and feed consumption were recorded 
when poults were 7 d of age. then, two blood samples were obtained from each poult of 
every pen. A similar protocol as described in Exp I was used to obtain plasma and to 
determine prothrombin time and plasma prothrombin concentration. Plasma obtained using 
heparin as anticoagulant also was analyzed to determine plasma K1 and menaquinone-4 
(MK-4) concentrations. 
Analytical Procedures 
Plasma KI and MK-4 levels were determined by colleagues at University of 
Wisconsin' using the high performance liquid chromatography (HPLC) method of Haroon et 
al. (1986). The following is a brief description of the method. Plasma samples were extracted 
through a liquid-phase with a ratio of plasma, water, ethanol. hexane at 1:2:3:9. After 
centrifiigation. the organic layer at the top of the supernatant was harvested and evaporated to 
dryness. The dried sample was resuspended in hexane, filtered through a silica Sep-Pak 
cartridge, and eluted with a 3% mixture of ether in hexane. Kl and MK-4 were analyzed on a 
HPLC with a Zorbax C18 reverse phase chromatography column, a zinc reduction column 
and a fluorescent detector. The zinc reduction column reduced vitamin K compounds to their 
' Dr. Suttie's group. Department of Biochemistry, University of Wisconsin. 
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fluorescent hydroquinones. The mobile solvent used was 15% methylene chloride in 
methanol with 5mL/L reductive solvent additive. The rate of solvent flow was set to 1.0 
mL/min, and pressure was 7757 cm merciuy. Excitation was performed at 244 run and 
emission was monitored at 418 nm. The internal standard used was di-hydrophylloquinone. 
One-stage prothrombin time was determined manually using a commercial 
thromboplastin preparation. Simplastin* Excel"*. The plasma prothrombin concentration was 
determined by an amidolysis assay (Shah el aL, 1984). The principle of the method was 
briefly; plasma prothrombin was activated to thrombin with a commercial preparation of 
thromboplastin. Simplastin"^ E.xcel". The thrombin produced catalyzed an amidolysis reaction 
of a specific chromogenic peptide substrate, Pefachrome TH"', to release p-nitroaniline. 
Concentration of p-nitroaniline was determined spectrophotometrically. A standard curve 
was developed with thrombin (EC 3.4.21.5)'* 
Statistical Analysis 
Data were analyzed using the General Linear Model (SAS Institute, 1996). When 
appropriate, a regression analysis (the one-slope or two-slope model, broken line method ) of 
Robbins (1986). was used to estimate the K.1 requirement. Single degree of freedom contrasts 
were used to determine differences among treatment means. Significance was declared when 
the probability was less than 5%. and a trend was announced when the probability was less 
than 10%. 
" Organon Teknika Corp.. Box 15969 Durham, NC 27704-0969 
' Centerchem. Inc.. 225 High Ridge Road, Stamford, CT 06905. 
^ Sigma Diagnostics Inc.. Sty. Louis, MO 63178. 
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RESULTS 
Experiment 1 
Inclusion of neomycin in the drinking water significantly increased body weight gain. 
However, inclusion of neomycin in the drinking water had no effect on feed intake and feed 
efficiency (Table 2). Plasma prothrombin time and prothrombin concentration were also not 
influenced by the inclusion of neomycin in water (Table 3). Dietary K1 had no effect on 
body weight gain, feed intake and efficiency of feed utilization (Table 2). However, dietary 
supplemental K1 at the level of O.lmg/kg significantly reduced prothrombin time and 
increased prothrombin concentration compared with those of poults fed the basal diet (Table 
3). Feeding the diet that contained 0.5 mg of Kl/kg did not decrease plasma prothrombin 
time, nor increase in prothrombin concentration beyond values obtained with 0.1 mg of 
Kl/kg. No interaction between neomycin and dietary Kl was detected for any parameters 
measured. 
Experiment 2 
Dietar\' KI had no effect on body weight gain, feed intake and efficiency of feed 
utilization (Table 4). However, plasma prothrombin time was decreased by dietary Kl 
supplementation (Table 5). Supplementation of 0.08 mg of Kl/kg in the basal diet was as 
effective as supplementation with 0.31. 0.44 or 1.8 mg of Kl/kg in reduction of prothrombin 
time. The estimated dietary Kl requirement of poults using the broken-line method was 
0.079 mg/kg. based on prothrombin time. 
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Experiment 3 
Body weight gain, feed intake and feed efficiency were not influenced by dietary 
supplemental of KI (Table 6). Dietary Kl, however, significantly affected plasma 
prothrombin time and plasma prothrombin concentration. Supplementation with 0.1 mg of 
K.l/kg tended to increase plasma prothrombin concentration and decrease plasma 
prothrombin time significantly compared with poults fed the basal diet (Table 7). Plasma 
prothrombin time was further decreased by supplementation of Kl at the level of 0.5 or more 
mg of Kl/kg compared to that of poults fed a diet supplemented with 0.1 mg of Kl/kg (Table 
7). Supplementation of diets with 0.25, 0.5 or 2.0 mg of Kl /kg, however, had no additional 
effect on plasma prothrombin concentration (Table 7 and Figure 3). The Kl requirements 
estimated using the broken line method were 0.099 mg and 0.13 mg/kg, based on plasma 
prothrombin time and prothrombin concentration, respectively. The concentrations of plasma 
K.1 increased linearly as the dietary Kl level increase. The concentration of plasma 
menaquinone-4 increased in a similar fashion as described above for the plasma Kl 
concentration as the dietary supplemental Kl level increasesd. 
DISCUSSION 
It was observed in the research reported here that inclusion of neomycin in drinking 
water for 7 days had no effect on plasma prothrombin time and prothrombin concentration. 
Frick el cil. (1967). however, reported that an intake of broad-spectrum antibiotic induced 
vitamin K deficiency in human beings when there was no dietary vitamin K source ingested. 
This discrepancy between the effect of ingestion of broad-spectrum antibiotics on the status 
of vitamin K observed in the research reported here and those observed by Frick et a/.(1967) 
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might indicate a difference in the importance of the bacterially synthesized menaqninones in 
the GI tract of turkeys and human beings as a source of vitamin K to meet their requirements. 
This discrepancy might be a result of the length difference of broad-spectrum antibiotics 
intake. Frick et«/.(1967) reported that vitamin K. deficiency developed in human being after 
21-28 days of intake of broad-spectrum antibiotics. A long period of broad-spectrum 
antibiotic intake also might result in substantial depletion of vitamin K stores of experimental 
animals whereas a short period of administration as done in the study reported here might not 
achieve sufUcient depletion. Conly (1992) stated that bacterially synthesized menaquinones, 
particularly those synthesized in the ileum, can and do contribute toward vitamin K 
requirements in humans in maintaining coagulation homeostasis, especially during periods of 
episodic dietary lack of the vitamin. 
In the research reported here, the estimated K.1 requirement was 0,099 mg/kg based 
on the influence of dietary Kl on plasma prothrombin concentration, which is a more 
specific and sensitive indicator of vitamin K. status than prothrombin time (Kindberg and 
Suttie. 1989). This estimation of Kl requirement based on the plasma prothrombin 
concentration was close to the Kl requirements obtained by the using of the broken line 
method to analyze data of prothrombin times in Exp. 2 and 3. The estimated Kl requirements 
using the latter method were 0.079 and 0.13 mg of Kl/kg. respectively. Griminger (1957) 
reported tliat the requirements of young turkeys were 1.1 or 1.75 mg/kg, respectively, when 
menadione sodium bisulfite or menadione requirement were used as vitamin K source. There 
are no data available on the potency ratio between menadione sodium bisulfite and Kl or 
menadione and Kl for turkeys. Thus it is impossible to estimate the Kl requirement of 
turkeys based on the data reported by Griminger (1957). Griminger and Donis (1960) 
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reported that the K.1 requirement of chicks fed a purified diet was I mg of Kl/kg diet. Nelson 
and Norris (1958) estimated the KI requirement for chicks varied from 0.4 to 0.6 mg of 
Kl/kg diet. This latter observation was confirmed by Nelson and Norris (I960), who reported 
that the K.1 requirement of chicks were 0.524 and 0.528 mg of Kl/kg diets, respectively. In 
all the research on the vitamin Kl requirement of chicks mentioned above, prothrombin time 
was used as the only criteria. It should be noted that plasma prothrombin time is a non­
specific index of vitamin K status and also is not a very sensitive index of vitamin K status 
(Kindberg and Suttie 1989). Using more sensitive and specific indicators of vitamin K, Suttie 
el cil. (1988) reported that the Kl requirement of a human was approximately Ijxg /kg body 
wt/d. If it assumed that the Kl requirement per unit of metabolic body weight was same for 
human beings and young turkeys, the calculated Kl requirement of 7- to l4-d-old turkeys 
should be less than 0.01 mg Kl/kg diet. 
Based on the influence of dietary Kl on plasma prothrombin concentration and 
prothrombin time, the estimated dietary Kl requirement of young turkeys is in the range of 
0.079 to 0.13 mg/kg. and ingestion of neomycin did not affect estimates of the requirement. 
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TABLE 1. Composition of the basal diet 
Ingredients Content 
(g/kg) 
Soybean meal (48%CP) 567.03 
Com starch 267.70 
Sunflower meal 80.00 
Stripped com oil 39.02 
Dicalcium phosphate 23.83 
Lime stone 12.67 
Vitamin premix' 3.00 
Mineral premix' 3.00 
DL-Methionine 2.00 
NaCl 1.50 
BMD^ 0.25 
Calculated nutrient composition 
ME. kcal/kg 2850 
CP. % 28.5 
TSAA. % 1.05 
Lysine. % 1.69 
Calcium, % 1.20 
Available phosphorus. % 0.60 
K1. mg/kg less than 0.02"*. 
Provided per kg diet: vitamin A (retinyl acetate). 8190 lU; dl-'^-tocopheryl acetate, 30 
lU: vitamin D3 (cholecalciferol). 1.650 lU, vitamin B12, 15.9 f^g; pantothenic acid, 13.2 
mg; niacin. 75 mg; choline, 5090 mg; folic acid, 2.4; biotin 0.27 mg; pyrodixine HCl 6.0 
mg: thiamine mononitrate 2.4 
• Supplied per kg diet: Mn. 70 mg; Zn, 40 mg; Fe, 37 mg; Cu, 6mg; Se, 0.15 mg; NaCl 
(I). 2.60 g. 
' Bacitracin dimethylene salicylate. 
^ Detection limit for vitamin Kl. 
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TABLE 2. EfTect of neomycin and dietary supplemental K1 on body weight gain, 
feed Intake and feed utilization in young turkey poults (Experiment 1) 
Neomycin Body weight Weight gain Feed intake Feed efficiency^ 
Supplemental KI Day 7 Day 1-7 Day 1-7 Day 1-7 
(mg/L) (mg/kg) g/poult 
0 143.3 81.9 73.4 0.869 
0 O.I 149.8 91.6 91.2 0.998 
0.5 15.4 91.7 89.9 0.980 
0 133.3 74.1 '76!2 L027 
75 O.I 135.1 76.5 80.4 1.051 
0.5 138.5 79.9 86.1 1.079 
SEM 5.23 5.44 0.064 5.68 
Means of main effect 
0 135.6 76.9 80.9 0.949 
Neomycin 
75 147.8 89.4 84.8 1.053 
0 138.3 79.6 74.8 0.948 
KI 0.1 142.5 84.1 85.8 1.025 
0.5 144.5 85.9 88.0 1.030 
Sources of variation 
Neomycin 
KI 
Neomycin x K.I 
0.03 0.03 
0.52 0.53 
0.90 0.92 
0.12 0.42 
0.44 0.097 
0.53 0.72 
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TABLE 3. Effect of neomycin and dietary supplemental K1 on plasma prothrombin 
time and prothrombin concentration (Experiment I) 
Neomycin Supplemental Kl Prothrombin time Prothrombin concentration' 
(mg/L) (mg/kg) (Seconds) (NIH)^ 
0 124.6 44.3 
0 0.1 112.5 104.0 
0.5 93.6 102.6 
0 129.7 31.4 
75 0.1 10.68 103.8 
0.5 101.2 120.8 
SEM 7.75 17.2 
Means of main effect 
Neomycin 
0 
Kl 
75 
0 
O.I 
0.5 
109.7 
112.1 
126.9" 
109.2" 
96.9'' 
83.6 
85.3 
137.8=^ 
103.9'' 
111.7'' 
Sources of variation 
Neomycin 
Kl 
Neomycin X K.I 
0.71 
0.0021 
0.90 
0.0004 
0.67 0.69 
^'' Means within a column with no common superscript differ significantly (P < 0.05). 
'prothrombin concentration is expressed in the terms of the activity of thrombin activity 
in NIH units. "NIH unit is obtained by direct comparison to a NIH Thrombin Reference 
Standard. Lot J. Sigma. St Louis. MO 63178 
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TABLE 4 Effect of dietary K1 on body weigiit gain, feed intake and eflHciency 
of feed utilization in young turkey poults (Experiment 2) 
Supplemental Body weight Weight gain Feed intake Feed efficiency' 
K1 Day? Day I-7 Day 1-7 Day 1-7 
^poult 
(mg/kg) 
0 129.7 72.9 80.8 1.116 
0.08 130.8 74.2 82.1 1.107 
0.31 136.6 79.8 86.2 1.080 
0.44 136.5 78.6 83.1 1.058 
1.8 138.2 80.7 85.9 1.065 
SEM 4.11 4.06 2.46 0.035 
Sources of variation 
K1 0.54 0.60 0.52 0.72 
' Feed to gain ratio. 
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TABLE 5. Effect of dietary Kl on plasma prothrombin time (Experiment 2) 
K:I Prothrombin time 
(mg/kg) (Seconds) 
0 130.4" 
0.08 88.9" 
0.31 98.7" 
0.44 100.7" 
1.80 92.3" 
SEM 7.59 
Sources of variation 
Kl 0.0011 
Means within a column with no conimon superscript differ significantly (P < 0.05). 
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TABLE 6. Effect of dietary supplemental K1 on body weight gain, feed intake 
and efficiency of feed utilization in young turkey poults (Experiment 3) 
Supplemental Body weight Weight gain Feed intake Feed efficiency' 
K1 Day 7 Days 1-7 Days 1-7 Days 1-7 
(mg/kg) g/poult 
0 133.3 74.2 76.2 1.027 
0.1 135.1 76.6 80.5 1.051 
0.25 137.1 78.3 82.1 1.049 
0.5 138.5 79.9 86.2 1.079 
2.0 144.8 86.0 90.2 1.051 
SEM 3.62 3.49 3.45 0.028 
Source of variation 
K1 0.34 0.30 0.18 0.78 
' Feed to gain ratio 
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TABLE 7. Effect of dietary supplemental K1 on plasma prothrombin time, and 
prothrombin concentration, and plasma Kl, menaquinone-4 (MK-4) 
concentrations in young turkey poults (Experiment 3). 
Kl Prothrombin time Prothrombin concentration' Plasma Kl MK-4 
(mg/kg) (Seconds) (NIH)- (ng/mL) 
0 124.6^' 44.3=" 0.27 0.83 
0.1 112.5'*'' 104.0" 0.66 1.27 
0.25 116.1" 92.8" 1.36 1.94 
0.5 94.6'-' 102.6" 1.95 1.94 
2.0 90.6'' 101.7" 7.23 6.21 
SEM 5.61 16.3 0.883 0.432 
Source of variation 
Kl 0.0001 0.078 0-0001 0.0001 
^ Means within a column with no common superscript differ significantly (P < 0.05). 
' prothrombin concentration is expressed by the activity of thrombin activity in NIH units. 
"NIH unit is obtained by direct comparison to a NIH Thrombin Reference Standard, Lot J. 
Sigma, St Louis. MO 63178. 
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MK-4 
Dietary supplemental Kl concentrations (mglcg) 
Figure 1. Effect of dietary supplemental Kl on plasma Kl arxi MK 
4 concentrations in 7-d-old turkeys. Experinent 3 
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GENERAL CONCLUSIONS 
The research reported herein had two objectives I) to determine the K1 requirement 
of turkey pouits. 2) to determine the influence of dietary K1 on bone mineralization and 
related plasma parameters in young turkeys fed diets that were adequate or deficient in D3. 
The results of this research showed that the dietary ICl requirement of 7- tol4-d-oId 
turkeys is in the range of 0.079 to 0.13 mg/kg, based on the effect of dietary supplemental K1 
on plasma prothrombin concentration and plasma prothrombin time. Administration of 
neomycin to minimize microbial synthesis of vitamin K. in the intestine did not affect 
estimates of the K1 requirement. The concentrations of plasma K1 increased linearly as the 
dietary supplemental Kl level increased. The concentration of plasma menaquinone-4 
increased in a similar fashion as that of plasma Kl as the dietary supplemental Kl level 
increase. Dietary supplemental Kl had little effect on bone development in poults fed diets 
either adequate or deficient in D3. even though Kl supplementation of D3 deficient diets 
increased plasma inorganic phosphorus and decreased plasma alkaline phosphatase. An 
increase in feed intake in response to Kl supplementation to the low D3 diet probably 
accounted for some of the changes in plasma alkaline phosphatase and inorganic phosphorus 
in poults fed a low vitamin D3 diet with supplemental Kl at a level of 0.37 or 2.88 mg of 
Kl/kg. The increase in bone ash caused by supplementation with a high level of Kl during a 
recovery from a rickets-like condition observed in Experiment 1 was not related to vitamin D 
status of the poults. The mechanism by which Kl had this effect is not evident from data 
obtained in the current study. 
